Professional Documents
Culture Documents
Perioperative Hemodynamic Monitoring and GDT Concepts in Trauma
Perioperative Hemodynamic Monitoring and GDT Concepts in Trauma
Perioperative Hemodynamic Monitoring and GDT Concepts in Trauma
Optimization Concepts
Dita Aditianingsih MD
Thursday, November 6, 14
Topics
Thursday, November 6, 14
High-Risk Surgery
Thursday, November 6, 14
Introduction Case
Male 83 y.o with Bladder
carcinoma, AKI – R, CAP
Elective Ileal conduit Surgery
with ASA 3
Thursday, November 6, 14
Female, 78 y.o, HHD, CHF gr 3-4,
septic shock ec diverticular
perforation , pneumoperitoneum.
Lactate 4, PCT 100
Intubated, CVC insertion
Fluid resuscitation with ivc usg
guided
Vasopressor, inotrope, broad
spectrum empirical antibiotics
Emergency Surgery with ASA 4
Post surgery :
Septic, AKI – F, VAP
Died in ICU 4 days later
Thursday, November 6, 14
Incidence
• Trauma, major surgery and severe sepsis are commonly associated
with life-threatening hypovolemia and reductions in myocardial
contractility and vascular tone.
• Account for the majority of peri-operative morbidity and mortality
(<15% of in patient procedures but >80% mortality)
• Have a poor outcome due to their inability to meet the oxygen
transport-demands imposed by the nature of the surgical response
during the peri-operative period.
• Optimal fluid administration combined with vasoactives aim to
prevent hypovolemia and end-organ hypoperfusion, but also
preventing edema formation from excessive fluid loading
Thursday, November 6, 14
Mortality following non-cardiac surgery in an NHS Trust
Thursday, November 6, 14
Mortality following non-cardiac surgery in an NHS Trust
Thursday, November 6, 14
Risk prediction for common surgical procedures
performed in the UK
Aylin et al. BMJ; 2007
Unruptured
Colo-rectal Ruptured AAA CABG
AAA
Effect of
Urgency 3.46 2.76 1.38 1.54
(odds ratio)
Unruptured
Colo-rectal Ruptured AAA CABG
AAA
Effect of
Urgency 3.46 2.76 1.38 1.54
(odds ratio)
Unruptured
Colo-rectal Ruptured AAA CABG
AAA
Effect of
Urgency 3.46 2.76 1.38 1.54
(odds ratio)
• Younger / Fitter /
Elective
Why are outcomes • Efficient care pathway for
so much better single disease group
• Post-operative intensive
for cardiac surgical patients? care is standard
Thursday, November 6, 14
Fleisher LA, Beckman JA, Brown KA, et al. ACC/
Thursday, November 6, 14
• POSSUM stands for Portsmouth-Physiological
and Operative Severity Score for the
enUmeration of Mortality and Morbidity.
• It was developed by Copeland et al in 1991
• Physiological parameters
• Operative parameters
Thursday, November 6, 14
NYHA, METS,
CPET
P-POSSUM
score,
ASA
BNP, CRP,
creatine,
GFR
Anaerobic
treshold <11 /kg/
min
Thursday, November 6, 14
NYHA, METS,
CPET
P-POSSUM
score,
ASA
BNP, CRP,
creatine,
GFR
Anaerobic
treshold <11 /kg/
min
Thursday, November 6, 14
NYHA, METS,
CPET
P-POSSUM
score,
ASA
BNP, CRP,
creatine,
GFR
Anaerobic
treshold <11 /kg/
min
Thursday, November 6, 14
Clinical criteria for high-risk
surgical patients
Pearse R, Dawson D, Fawcett J, Rhodes A, Grounds RM, Bennett ED. Early goal directed therapy after major surgery reduces complications and
duration of hospital stay. A randomised controlled trial. Crit Care 2005; 9: R687–93
Thursday, November 6, 14
Relationship
between
perioperative
fluid
volume
and
post-‐operative
morbidity
Morbidity
Bundgaard-‐Nielsen
M,
et
al.
‘Liberal’
vs.
‘restrictive’
perioperative
fluid
therapy—a
critical
assessment
of
the
evidence.
Acta
Anaesthesiol
Scand
2009
Thursday, November 6, 14
Relationship
between
perioperative
fluid
volume
and
post-‐operative
morbidity
Morbidity
Bundgaard-‐Nielsen
M,
et
al.
‘Liberal’
vs.
‘restrictive’
perioperative
fluid
therapy—a
critical
assessment
of
the
evidence.
Acta
Anaesthesiol
Scand
2009
Thursday, November 6, 14
Relationship
between
perioperative
fluid
volume
and
post-‐operative
morbidity
Morbidity
Procedure
Comorbidities
Preop
hydration
Bowel
preparation
Anaesthesia/neuroaxial
blockade
Bundgaard-‐Nielsen
M,
et
al.
‘Liberal’
vs.
‘restrictive’
perioperative
fluid
therapy—a
critical
assessment
of
the
evidence.
Acta
Anaesthesiol
Scand
2009
Thursday, November 6, 14
Relationship
between
perioperative
fluid
volume
and
post-‐operative
morbidity
Morbidity
Procedure
Comorbidities
Preop
hydration
Restrictive Bowel
preparation
Anaesthesia/neuroaxial
blockade
Bundgaard-‐Nielsen
M,
et
al.
‘Liberal’
vs.
‘restrictive’
perioperative
fluid
therapy—a
critical
assessment
of
the
evidence.
Acta
Anaesthesiol
Scand
2009
Thursday, November 6, 14
Relationship
between
perioperative
fluid
volume
and
post-‐operative
morbidity
Morbidity
Procedure
Comorbidities
Preop
hydration
Restrictive Bowel
preparation
Anaesthesia/neuroaxial
blockade
Hypovolemia
Bundgaard-‐Nielsen
M,
et
al.
‘Liberal’
vs.
‘restrictive’
perioperative
fluid
therapy—a
critical
assessment
of
the
evidence.
Acta
Anaesthesiol
Scand
2009
Thursday, November 6, 14
Relationship
between
perioperative
fluid
volume
and
post-‐operative
morbidity
Morbidity
Procedure
Comorbidities
Preop
hydration
Restrictive Bowel
preparation
Anaesthesia/neuroaxial
blockade
Bowel ischemia
Hypovolemia
Bundgaard-‐Nielsen
M,
et
al.
‘Liberal’
vs.
‘restrictive’
perioperative
fluid
therapy—a
critical
assessment
of
the
evidence.
Acta
Anaesthesiol
Scand
2009
Thursday, November 6, 14
Relationship
between
perioperative
fluid
volume
and
post-‐operative
morbidity
Morbidity
Procedure
Comorbidities
Preop
hydration
Restrictive Bowel
preparation
Anaesthesia/neuroaxial
blockade
Bowel
ischemia
é
risk
of:
Organ
hypoperfusion
SIRS
Sepsis
MOF
Hypovolemia
Bundgaard-‐Nielsen
M,
et
al.
‘Liberal’
vs.
‘restrictive’
perioperative
fluid
therapy—a
critical
assessment
of
the
evidence.
Acta
Anaesthesiol
Scand
2009
Thursday, November 6, 14
Relationship
between
perioperative
fluid
volume
and
post-‐operative
morbidity
Morbidity
Procedure
Comorbidities
Preop
hydration
Restrictive Bowel
preparation Liberal
Anaesthesia/neuroaxial
blockade
Bowel
ischemia
é
risk
of:
Organ
hypoperfusion
SIRS
Sepsis
MOF
Hypovolemia
Bundgaard-‐Nielsen
M,
et
al.
‘Liberal’
vs.
‘restrictive’
perioperative
fluid
therapy—a
critical
assessment
of
the
evidence.
Acta
Anaesthesiol
Scand
2009
Thursday, November 6, 14
Relationship
between
perioperative
fluid
volume
and
post-‐operative
morbidity
Morbidity
Procedure
Comorbidities
Preop
hydration
Restrictive Bowel
preparation Liberal
Anaesthesia/neuroaxial
blockade
Bowel
ischemia
é
risk
of:
Organ
hypoperfusion
SIRS
Sepsis
MOF
Hypovolemia Hypervolemia
Bundgaard-‐Nielsen
M,
et
al.
‘Liberal’
vs.
‘restrictive’
perioperative
fluid
therapy—a
critical
assessment
of
the
evidence.
Acta
Anaesthesiol
Scand
2009
Thursday, November 6, 14
Relationship
between
perioperative
fluid
volume
and
post-‐operative
morbidity
Morbidity
Procedure
Comorbidities
Preop
hydration
Restrictive Bowel
preparation Liberal
Anaesthesia/neuroaxial
blockade
Hypovolemia Hypervolemia
Bundgaard-‐Nielsen
M,
et
al.
‘Liberal’
vs.
‘restrictive’
perioperative
fluid
therapy—a
critical
assessment
of
the
evidence.
Acta
Anaesthesiol
Scand
2009
Thursday, November 6, 14
Relationship
between
perioperative
fluid
volume
and
post-‐operative
morbidity
Morbidity
Procedure
Comorbidities
Preop
hydration
Restrictive Bowel
preparation Liberal
Anaesthesia/neuroaxial
blockade
Hypovolemia Hypervolemia
Bundgaard-‐Nielsen
M,
et
al.
‘Liberal’
vs.
‘restrictive’
perioperative
fluid
therapy—a
critical
assessment
of
the
evidence.
Acta
Anaesthesiol
Scand
2009
Thursday, November 6, 14
Relationship
between
perioperative
fluid
volume
and
post-‐operative
morbidity
Morbidity
Procedure
Comorbidities
Preop
hydration
Restrictive Bowel
preparation Liberal
Anaesthesia/neuroaxial
blockade
Hypovolemia
Normovolemia Hypervolemia
Bundgaard-‐Nielsen
M,
et
al.
‘Liberal’
vs.
‘restrictive’
perioperative
fluid
therapy—a
critical
assessment
of
the
evidence.
Acta
Anaesthesiol
Scand
2009
Thursday, November 6, 14
Relationship
between
perioperative
fluid
volume
and
post-‐operative
morbidity
Morbidity
Procedure
Comorbidities
Preop
hydration
Restrictive Bowel
preparation Liberal
Anaesthesia/neuroaxial
blockade
Hypovolemia
Normovolemia Hypervolemia
Bundgaard-‐Nielsen
M,
et
al.
‘Liberal’
vs.
‘restrictive’
perioperative
fluid
therapy—a
critical
assessment
of
the
evidence.
Acta
Anaesthesiol
Scand
2009
Thursday, November 6, 14
Relationship
between
perioperative
fluid
volume
and
post-‐operative
morbidity
Morbidity
Procedure
Comorbidities
Preop
hydration
Restrictive Bowel
preparation Liberal
Anaesthesia/neuroaxial
blockade
Hypovolemia
Normovolemia Hypervolemia
Bundgaard-‐Nielsen
M,
et
al.
‘Liberal’
vs.
‘restrictive’
perioperative
fluid
therapy—a
critical
assessment
of
the
evidence.
Acta
Anaesthesiol
Scand
2009
Thursday, November 6, 14
Pathophysiology: Why do patients
develop postoperative complications?
Thursday, November 6, 14
Pathophysiology: Why do patients
develop postoperative complications?
Thursday, November 6, 14
Tissue oxygen delivery (DO2)
and oxygen consumption (VO2)
• DO2=CO x CaO2
=CO × (1.34 × Hb × SaO2)
• VO2 = CO x (CaO2 - CvO2)
= CO x 1.34 x Hb x (SaO2 - SvO2)
• OER is the ratio of VO2 to DO2, and
organ specific
Basal metabolism :
VO2 of 250–300 mL/minute, i.e. 3.5 mL/kg.
pain, anxiety, sepsis, fever increase VO2
hypothermia, anesthesia, hypothermia decrease VO2
Thursday, November 6, 14
Oxygen Delivery - Oxygen
Consumption Relationship Curve
Thursday, November 6, 14
Oxygen Delivery - Oxygen
Consumption Relationship Curve
Thursday, November 6, 14
Oxygen Delivery - Oxygen
Consumption Relationship Curve
OXYGEN CONSUMPTION (VO2)
OXYGEN Extraction (O2ER)
Thursday, November 6, 14
Oxygen Delivery - Oxygen
Consumption Relationship Curve
OXYGEN CONSUMPTION (VO2)
OXYGEN Extraction (O2ER)
Thursday, November 6, 14
Oxygen Delivery - Oxygen
Consumption Relationship Curve
OXYGEN CONSUMPTION (VO2)
OXYGEN Extraction (O2ER)
Thursday, November 6, 14
Oxygen Delivery - Oxygen
Consumption Relationship Curve
Thursday, November 6, 14
Oxygen Delivery - Oxygen
Consumption Relationship Curve
Shock
NORMAL PHYSIOLOGIC STATE
oxygen
Thursday, November 6, 14
Oxygen Delivery - Oxygen
Consumption Relationship Curve
Shock
NORMAL PHYSIOLOGIC STATE
oxygen
Thursday, November 6, 14
Oxygen Delivery - Oxygen
Consumption Relationship Curve
Shock
NORMAL PHYSIOLOGIC STATE
oxygen
Thursday, November 6, 14
Oxygen Delivery - Oxygen
Consumption Relationship Curve
Shock
NORMAL PHYSIOLOGIC STATE
oxygen
Thursday, November 6, 14
Oxygen Delivery - Oxygen
Consumption Relationship Curve
Shock
NORMAL PHYSIOLOGIC STATE
oxygen
Thursday, November 6, 14
Oxygen Delivery - Oxygen
Consumption Relationship Curve
SvO2
Shock
NORMAL PHYSIOLOGIC STATE
oxygen
Thursday, November 6, 14
Oxygen Delivery - Oxygen
Consumption Relationship Curve
SvO2
Shock
NORMAL PHYSIOLOGIC STATE
oxygen
lactate
Base deficit
OXYGEN DELIVERY (DO2)
Thursday, November 6, 14
Oxygen Delivery - Oxygen
Consumption Relationship Curve
SvO2
Shock
NORMAL PHYSIOLOGIC STATE
oxygen
lactate
Base deficit
OXYGEN DELIVERY (DO2)
Thursday, November 6, 14
Perioperative Hemodynamic
Instabilities
⬇︎Blood Pressure- ⬇︎Cardiac Output ⬇︎Systemic Vascular Resistance
Mean Arterial Pressure CO SVR
Thursday, November 6, 14
Perioperative Hemodynamic
Instabilities
⬇︎Blood Pressure-
Mean Arterial Pressure
= ⬇︎Cardiac
CO
Output ⬇︎Systemic Vascular Resistance
SVR
Thursday, November 6, 14
Perioperative Hemodynamic
Instabilities
⬇︎Blood Pressure-
Mean Arterial Pressure
= ⬇︎Cardiac
CO
Output
x ⬇︎Systemic Vascular Resistance
SVR
Thursday, November 6, 14
Perioperative Hemodynamic
Instabilities
⬇︎Blood Pressure-
Mean Arterial Pressure
= ⬇︎Cardiac
CO
Output
x ⬇︎Systemic Vascular Resistance
SVR
Thursday, November 6, 14
Perioperative Hemodynamic
Instabilities
⬇︎Blood Pressure-
Mean Arterial Pressure
= ⬇︎Cardiac
CO
Output
x ⬇︎Systemic Vascular Resistance
SVR
Thursday, November 6, 14
Perioperative Hemodynamic
Instabilities
⬇︎Blood Pressure-
Mean Arterial Pressure
= ⬇︎Cardiac
CO
Output
x ⬇︎Systemic Vascular Resistance
SVR
Thursday, November 6, 14
Perioperative Hemodynamic
Instabilities
⬇︎Blood Pressure-
Mean Arterial Pressure
= ⬇︎Cardiac
CO
Output
x ⬇︎Systemic Vascular Resistance
SVR
Thursday, November 6, 14
Perioperative Hemodynamic
Instabilities
⬇︎Blood Pressure-
Mean Arterial Pressure
= ⬇︎Cardiac
CO
Output
x ⬇︎Systemic Vascular Resistance
SVR
Thursday, November 6, 14
Perioperative Hemodynamic
Instabilities
⬇︎Blood Pressure-
Mean Arterial Pressure
= ⬇︎Cardiac
CO
Output
x ⬇︎Systemic Vascular Resistance
SVR
Thursday, November 6, 14
Perioperative Hemodynamic
Instabilities
⬇︎Blood Pressure-
Mean Arterial Pressure
= ⬇︎Cardiac
CO
Output
x ⬇︎Systemic Vascular Resistance
SVR
Thursday, November 6, 14
Perioperative Hemodynamic
Instabilities
⬇︎Blood Pressure-
Mean Arterial Pressure
= ⬇︎Cardiac
CO
Output
x ⬇︎Systemic Vascular Resistance
SVR
Thursday, November 6, 14
Perioperative Hemodynamic
Instabilities
⬇︎Blood Pressure-
Mean Arterial Pressure
= ⬇︎Cardiac
CO
Output
x ⬇︎Systemic Vascular Resistance
SVR
Thursday, November 6, 14
Perioperative Hemodynamic
Instabilities
⬇︎Blood Pressure-
Mean Arterial Pressure
= ⬇︎Cardiac
CO
Output
x ⬇︎Systemic Vascular Resistance
SVR
Thursday, November 6, 14
Perioperative Hemodynamic
Instabilities
⬇︎Blood Pressure-
Mean Arterial Pressure
= ⬇︎Cardiac
CO
Output
x ⬇︎Systemic Vascular Resistance
SVR
Thursday, November 6, 14
Perioperative Hemodynamic
Instabilities
⬇︎Blood Pressure-
Mean Arterial Pressure
= ⬇︎Cardiac
CO
Output
x ⬇︎Systemic Vascular Resistance
SVR
Thursday, November 6, 14
Perioperative Hemodynamic
Instabilities
⬇︎Blood Pressure-
Mean Arterial Pressure
= ⬇︎Cardiac
CO
Output
x ⬇︎Systemic Vascular Resistance
SVR
Thursday, November 6, 14
Perioperative Hemodynamic
Instabilities
⬇︎Blood Pressure-
Mean Arterial Pressure
= ⬇︎Cardiac
CO
Output
x ⬇︎Systemic Vascular Resistance
SVR
Thursday, November 6, 14
Supranormal Target using The Frank-Starling curve representing
the non-linear relationship between
ventricular preload and ventricular stroke volume
Cardiac Output
Thursday, November 6, 14
Supranormal Target using The Frank-Starling curve representing
the non-linear relationship between
ventricular preload and ventricular stroke volume
Cardiac Output
Thursday, November 6, 14
Supranormal Target using The Frank-Starling curve representing
the non-linear relationship between
ventricular preload and ventricular stroke volume
Cardiac Output
Thursday, November 6, 14
Supranormal Target using The Frank-Starling curve representing
the non-linear relationship between
ventricular preload and ventricular stroke volume
Cardiac Output
Cardiac Output
⬇︎Contractility impaired
• Respiratory management :
- Early vs delayed intubation
- Early vs delayed extubation
- CPAP
• Cardiovascular management:
- Inotropes and rate control
- Fluid therapy : restrictive vs liberal
- Perioperative Goal-Directed
Haemodynamic therapy
Thursday, November 6, 14
Goal-Directed Therapy (GDT)
Thursday, November 6, 14
Pulmonary arterial pressures, HR.
MAP,CVP, pulmonary capillary WP
Arterial and mixed venous saturation,
pH, blood gas tensions,hemoglobin,
hemoglobin saturation, hematocrit
Cardiac output then was measured by
thermodilution
DO2 measured by calculated CI and
arterial oxygen content (per BSA)
Thursday, November 6, 14
Pulmonary arterial pressures, HR.
MAP,CVP, pulmonary capillary WP
Arterial and mixed venous saturation,
pH, blood gas tensions,hemoglobin,
hemoglobin saturation, hematocrit
Cardiac output then was measured by
thermodilution
DO2 measured by calculated CI and
arterial oxygen content (per BSA)
Thursday, November 6, 14
Pulmonary arterial pressures, HR.
MAP,CVP, pulmonary capillary WP
Arterial and mixed venous saturation,
pH, blood gas tensions,hemoglobin,
hemoglobin saturation, hematocrit
Cardiac output then was measured by
thermodilution
DO2 measured by calculated CI and
arterial oxygen content (per BSA)
Thursday, November 6, 14
Thursday, November 6, 14
Thursday, November 6, 14
Thursday, November 6, 14
The Goal Directed Therapy
includes :
fluid loading , tranfusion and
inotropes, to optimize the
preload, contractility and
afterload of the heart and
maintaining an adequate
coronary perfusion pressure
Thursday, November 6, 14
The Goal Directed Therapy
includes :
fluid loading , tranfusion and
inotropes, to optimize the
preload, contractility and
afterload of the heart and
maintaining an adequate
coronary perfusion pressure
Thursday, November 6, 14
The Goal Directed Therapy
includes :
fluid loading , tranfusion and
inotropes, to optimize the
preload, contractility and
afterload of the heart and
maintaining an adequate
coronary perfusion pressure
Thursday, November 6, 14
Static : CVP, PAOP
Volumetric : PAC, PICCO,
LidCO
Echocardiographic : Echo,
TEE
Dynamic : SVV, PPV, PLR
Treatment group
Treatment group
Control group
control group
Thursday, November 6, 14
Optimisation of Patients in ICU
Thursday, November 6, 14
Individualized
Goal-Directed
Therapy
Thursday, November 6, 14
Hypotension is always a bad sign,
but shock is not always hypotension
Normal Blood Pressure- Normal Cardiac Normal Systemic Vascular
Mean Arterial Pressure Output Resistance
Thursday, November 6, 14
Hypotension is always a bad sign,
but shock is not always hypotension
Normal Blood Pressure- Normal Cardiac Normal Systemic Vascular
Mean Arterial Pressure = Output Resistance
Thursday, November 6, 14
Hypotension is always a bad sign,
but shock is not always hypotension
Normal Blood Pressure- Normal Cardiac Normal Systemic Vascular
Mean Arterial Pressure = Output x Resistance
Thursday, November 6, 14
Hypotension is always a bad sign,
but shock is not always hypotension
Normal Blood Pressure- Normal Cardiac Normal Systemic Vascular
Mean Arterial Pressure = Output x Resistance
Thursday, November 6, 14
Hypotension is always a bad sign,
but shock is not always hypotension
Normal Blood Pressure- Normal Cardiac Normal Systemic Vascular
Mean Arterial Pressure = Output x Resistance
Thursday, November 6, 14
Hypotension is always a bad sign,
but shock is not always hypotension
Normal Blood Pressure- Normal Cardiac Normal Systemic Vascular
Mean Arterial Pressure = Output x Resistance
Thursday, November 6, 14
Hypotension is always a bad sign,
but shock is not always hypotension
Normal Blood Pressure- Normal Cardiac Normal Systemic Vascular
Mean Arterial Pressure = Output x Resistance
Thursday, November 6, 14
Hypotension is always a bad sign,
but shock is not always hypotension
Normal Blood Pressure- Normal Cardiac Normal Systemic Vascular
Mean Arterial Pressure = Output x Resistance
Fluid challange
Fluid challange
MAP>65 mmHg CVP 8-12 mmHg
Vasoactives
Observe Re-evaluate
1. OVERLOAD
Premed BIS 65 2. INTRAOP AWAKENING INCREASE
VO2 OVER DO2: Oxygen debt
90 BIS 45 BIS 55
80 BIS 75 1.0
1.5
70 Intubation Bowel/
Prep Incision Vasc
0.0
60 clamping/ Recovery 0.5
Anxiety Sleep Peritonel bleeding
MAP traction ICU MAC
Duration of surgery Modified from Mayer et al. Critical Care 2010, 14:R18
George 2014
Thursday, November 6, 14
Perioperative Goal-directed Therapy
Traditional Approach for Moderate Risk Surgery
MAP>65mmHg Urine Output >0.5ml/kg/hr Goal directed Therapy:
YES Target: Blood Pressure
CVP 8-12 mmHg CVP <8 mmHg (MAP 65-90), BIS 40-60
Intervention :
Anesthetic dose, Fluid
Fluid challange Vasoactives
Stress response
Fluid challange
Fluid challange
MAP>65 mmHg CVP 8-12 mmHg
Vasoactives
Observe Re-evaluate
1. OVERLOAD
Premed BIS 65 2. INTRAOP AWAKENING INCREASE
VO2 OVER DO2: Oxygen debt
90 BIS 45 BIS 55
80 BIS 75 1.0
1.5
70 Intubation Bowel/
Prep Incision Vasc
0.0
60 clamping/ Recovery 0.5
Anxiety Sleep Peritonel bleeding
MAP traction ICU MAC
Duration of surgery Modified from Mayer et al. Critical Care 2010, 14:R18
George 2014
Thursday, November 6, 14
Perioperative Goal-directed Therapy
Traditional Approach for Moderate Risk Surgery
MAP>65mmHg Urine Output >0.5ml/kg/hr Goal directed Therapy:
YES Target: Blood Pressure
CVP 8-12 mmHg CVP <8 mmHg (MAP 65-90), BIS 40-60
Intervention :
Anesthetic dose, Fluid
Fluid challange Vasoactives
Stress response
Fluid challange
MAP>65 mmHg CVP 8-12 mmHg
Vasoactives
Observe Re-evaluate
1. OVERLOAD
Premed BIS 65 2. INTRAOP AWAKENING INCREASE
VO2 OVER DO2: Oxygen debt
90 BIS 45 BIS 55
80 BIS 75 1.0
1.5
70 Intubation Bowel/
Prep Incision Vasc
0.0
60 clamping/ Recovery 0.5
Anxiety Sleep Peritonel bleeding
MAP traction ICU MAC
Duration of surgery Modified from Mayer et al. Critical Care 2010, 14:R18
George 2014
Thursday, November 6, 14
Perioperative Goal-directed Therapy
Traditional Approach for Moderate Risk Surgery
MAP>65mmHg Urine Output >0.5ml/kg/hr Goal directed Therapy:
YES NO Target: Blood Pressure
CVP 8-12 mmHg CVP <8 mmHg (MAP 65-90), BIS 40-60
Intervention :
Anesthetic dose, Fluid
Fluid challange Vasoactives
Stress response
Fluid challange
MAP>65 mmHg CVP 8-12 mmHg
Vasoactives
Observe Re-evaluate
1. OVERLOAD
Premed BIS 65 2. INTRAOP AWAKENING INCREASE
VO2 OVER DO2: Oxygen debt
90 BIS 45 BIS 55
80 BIS 75 1.0
1.5
70 Intubation Bowel/
Prep Incision Vasc
0.0
60 clamping/ Recovery 0.5
Anxiety Sleep Peritonel bleeding
MAP traction ICU MAC
Duration of surgery Modified from Mayer et al. Critical Care 2010, 14:R18
George 2014
Thursday, November 6, 14
Perioperative Goal-directed Therapy
Traditional Approach for Moderate Risk Surgery
MAP>65mmHg Urine Output >0.5ml/kg/hr Goal directed Therapy:
YES NO Target: Blood Pressure
CVP 8-12 mmHg CVP <8 mmHg (MAP 65-90), BIS 40-60
Intervention :
Anesthetic dose, Fluid
Fluid challange Vasoactives
Stress response
Fluid challange
MAP>65 mmHg CVP 8-12 mmHg
Vasoactives
Observe Re-evaluate
1. OVERLOAD
Premed BIS 65 2. INTRAOP AWAKENING INCREASE
VO2 OVER DO2: Oxygen debt
90 BIS 45 BIS 55
80 BIS 75 1.0
1.5
70 Intubation Bowel/
Prep Incision Vasc
0.0
60 clamping/ Recovery 0.5
Anxiety Sleep Peritonel bleeding
MAP traction ICU MAC
Duration of surgery Modified from Mayer et al. Critical Care 2010, 14:R18
George 2014
Thursday, November 6, 14
Perioperative Goal-directed Therapy
Traditional Approach for Moderate Risk Surgery
MAP>65mmHg Urine Output >0.5ml/kg/hr Goal directed Therapy:
YES NO Target: Blood Pressure
CVP 8-12 mmHg CVP <8 mmHg (MAP 65-90), BIS 40-60
Intervention :
Anesthetic dose, Fluid
Fluid challange Vasoactives
Stress response
Fluid challange
MAP>65 mmHg CVP 8-12 mmHg
NO Vasoactives
Observe Re-evaluate
1. OVERLOAD
Premed BIS 65 2. INTRAOP AWAKENING INCREASE
VO2 OVER DO2: Oxygen debt
90 BIS 45 BIS 55
80 BIS 75 1.0
1.5
70 Intubation Bowel/
Prep Incision Vasc
0.0
60 clamping/ Recovery 0.5
Anxiety Sleep Peritonel bleeding
MAP traction ICU MAC
Duration of surgery Modified from Mayer et al. Critical Care 2010, 14:R18
George 2014
Thursday, November 6, 14
Perioperative Goal-directed Therapy
Traditional Approach for Moderate Risk Surgery
MAP>65mmHg Urine Output >0.5ml/kg/hr Goal directed Therapy:
YES NO Target: Blood Pressure
CVP 8-12 mmHg CVP <8 mmHg (MAP 65-90), BIS 40-60
Intervention :
Anesthetic dose, Fluid
Fluid challange Vasoactives
Stress response
Fluid challange
MAP>65 mmHg CVP 8-12 mmHg
NO Vasoactives
YES
Observe Re-evaluate
1. OVERLOAD
Premed BIS 65 2. INTRAOP AWAKENING INCREASE
VO2 OVER DO2: Oxygen debt
90 BIS 45 BIS 55
80 BIS 75 1.0
1.5
70 Intubation Bowel/
Prep Incision Vasc
0.0
60 clamping/ Recovery 0.5
Anxiety Sleep Peritonel bleeding
MAP traction ICU MAC
Duration of surgery Modified from Mayer et al. Critical Care 2010, 14:R18
George 2014
Thursday, November 6, 14
Perioperative Goal-directed Therapy
Traditional Approach for Moderate Risk Surgery
MAP>65mmHg Urine Output >0.5ml/kg/hr Goal directed Therapy:
YES NO Target: Blood Pressure
CVP 8-12 mmHg CVP <8 mmHg (MAP 65-90), BIS 40-60
Intervention :
Anesthetic dose, Fluid
Fluid challange Vasoactives
Stress response
Fluid challange
MAP>65 mmHg CVP 8-12 mmHg
NO Vasoactives
YES
Observe Re-evaluate
1. OVERLOAD
Premed BIS 65 2. INTRAOP AWAKENING INCREASE
VO2 OVER DO2: Oxygen debt
90 BIS 45 BIS 55
80 BIS 75 1.0
1.5
70 Intubation Bowel/
Prep Incision Vasc
0.0
60 clamping/ Recovery 0.5
Anxiety Sleep Peritonel bleeding
MAP traction ICU MAC
Duration of surgery Modified from Mayer et al. Critical Care 2010, 14:R18
George 2014
Thursday, November 6, 14
Perioperative Goal-directed Therapy
Traditional Approach for Moderate Risk Surgery
MAP>65mmHg Urine Output >0.5ml/kg/hr Goal directed Therapy:
YES NO Target: Blood Pressure
CVP 8-12 mmHg CVP <8 mmHg (MAP 65-90), BIS 40-60
Intervention :
Anesthetic dose, Fluid
Fluid challange Vasoactives
Stress response
Fluid challange
MAP>65 mmHg CVP 8-12 mmHg
NO Vasoactives
YES
Observe Re-evaluate
1. OVERLOAD
Premed BIS 65 2. INTRAOP AWAKENING INCREASE
VO2 OVER DO2: Oxygen debt
90 BIS 45 BIS 55
80 BIS 75 1.0
1.5
70 Intubation Bowel/
Prep Incision Vasc
0.0
60 clamping/ Recovery 0.5
Anxiety Sleep Peritonel bleeding
MAP traction ICU MAC
Duration of surgery Modified from Mayer et al. Critical Care 2010, 14:R18
George 2014
Thursday, November 6, 14
Perioperative Goal-directed Therapy
Traditional Approach for Moderate Risk Surgery
MAP>65mmHg Urine Output >0.5ml/kg/hr Goal directed Therapy:
YES NO Target: Blood Pressure
CVP 8-12 mmHg CVP <8 mmHg (MAP 65-90), BIS 40-60
Intervention :
Anesthetic dose, Fluid
Fluid challange Vasoactives
Stress response
Fluid challange
MAP>65 mmHg CVP 8-12 mmHg
NO Vasoactives
YES
Observe Re-evaluate
1. OVERLOAD
Premed BIS 65 2. INTRAOP AWAKENING INCREASE
VO2 OVER DO2: Oxygen debt
90 BIS 45 BIS 55
80 BIS 75 1.0
1.5
70 Intubation Bowel/
Prep Incision Vasc
0.0
60 clamping/ Recovery 0.5
Anxiety Sleep Peritonel bleeding
MAP traction ICU MAC
Duration of surgery Modified from Mayer et al. Critical Care 2010, 14:R18
George 2014
Thursday, November 6, 14
Perioperative Goal-directed Therapy
Individualized Approach for High-Risk Surgery
Lactate >1,
CI ≥ 2.5 L/min ScvO2 <70%
Oxygen YES NO NO
Delivery
MAP SVI < 35 ml/min SVI > 35 ml/min
90 60
Bi-spectral Index
40 2.0
70 Intubation Bowel/
Prep Incision Vasc 1.5
60 clamping/ Recovery
Anxiety Sleep Peritonel bleeding 0.5
MAP traction ICU MAC
Duration of surgery Modified from Mayer et al. Critical Care 2010, 14:R18
George 2014
Thursday, November 6, 14
Perioperative Goal-directed Therapy
Individualized Approach for High-Risk Surgery
Lactate >1,
CI ≥ 2.5 L/min ScvO2 <70%
Oxygen YES NO NO
Delivery
MAP SVI < 35 ml/min SVI > 35 ml/min
90 60
Bi-spectral Index
40 2.0
70 Intubation Bowel/
Prep Incision Vasc 1.5
60 clamping/ Recovery
Anxiety Sleep Peritonel bleeding 0.5
MAP traction ICU MAC
Duration of surgery Modified from Mayer et al. Critical Care 2010, 14:R18
George 2014
Thursday, November 6, 14
Perioperative Goal-directed Therapy
Individualized Approach for High-Risk Surgery
Lactate >1,
CI ≥ 2.5 L/min ScvO2 <70%
Oxygen YES NO NO
Delivery
MAP SVI < 35 ml/min SVI > 35 ml/min
90 60
Bi-spectral Index
40 2.0
70 Intubation Bowel/
Prep Incision Vasc 1.5
60 clamping/ Recovery
Anxiety Sleep Peritonel bleeding 0.5
MAP traction ICU MAC
Duration of surgery Modified from Mayer et al. Critical Care 2010, 14:R18
George 2014
Thursday, November 6, 14
Perioperative Goal-directed Therapy
Individualized Approach for High-Risk Surgery
Lactate >1,
CI ≥ 2.5 L/min ScvO2 <70%
Oxygen YES NO NO
Delivery
MAP SVI < 35 ml/min SVI > 35 ml/min
90 60
Bi-spectral Index
40 2.0
70 Intubation Bowel/
Prep Incision Vasc 1.5
60 clamping/ Recovery
Anxiety Sleep Peritonel bleeding 0.5
MAP traction ICU MAC
Duration of surgery Modified from Mayer et al. Critical Care 2010, 14:R18
George 2014
Thursday, November 6, 14
Perioperative Goal-directed Therapy
Individualized Approach for High-Risk Surgery
Lactate >1,
CI ≥ 2.5 L/min ScvO2 <70%
Oxygen YES NO NO
Delivery
MAP SVI < 35 ml/min SVI > 35 ml/min
90 60
Bi-spectral Index
40 2.0
70 Intubation Bowel/
Prep Incision Vasc 1.5
60 clamping/ Recovery
Anxiety Sleep Peritonel bleeding 0.5
MAP traction ICU MAC
Duration of surgery Modified from Mayer et al. Critical Care 2010, 14:R18
George 2014
Thursday, November 6, 14
Perioperative Goal-directed Therapy
Individualized Approach for High-Risk Surgery
Lactate >1,
CI ≥ 2.5 L/min ScvO2 <70%
Oxygen YES NO NO
Delivery
MAP SVI < 35 ml/min SVI > 35 ml/min
90 60
Bi-spectral Index
40 2.0
70 Intubation Bowel/
Prep Incision Vasc 1.5
60 clamping/ Recovery
Anxiety Sleep Peritonel bleeding 0.5
MAP traction ICU MAC
Duration of surgery Modified from Mayer et al. Critical Care 2010, 14:R18
George 2014
Thursday, November 6, 14
Perioperative Goal-directed Therapy
Individualized Approach for High-Risk Surgery
Lactate >1,
CI ≥ 2.5 L/min ScvO2 <70%
Oxygen YES NO NO
Delivery
MAP SVI < 35 ml/min SVI > 35 ml/min
90 60
Bi-spectral Index
40 2.0
70 Intubation Bowel/
Prep Incision Vasc 1.5
60 clamping/ Recovery
Anxiety Sleep Peritonel bleeding 0.5
MAP traction ICU MAC
Duration of surgery Modified from Mayer et al. Critical Care 2010, 14:R18
George 2014
Thursday, November 6, 14
Perioperative Goal-directed Therapy
Individualized Approach for High-Risk Surgery
Lactate >1,
CI ≥ 2.5 L/min ScvO2 <70%
Oxygen YES NO NO
Delivery
MAP SVI < 35 ml/min SVI > 35 ml/min
90 60
Bi-spectral Index
40 2.0
70 Intubation Bowel/
Prep Incision Vasc 1.5
60 clamping/ Recovery
Anxiety Sleep Peritonel bleeding 0.5
MAP traction ICU MAC
Duration of surgery Modified from Mayer et al. Critical Care 2010, 14:R18
George 2014
Thursday, November 6, 14
Perioperative Goal-directed Therapy
Individualized Approach for High-Risk Surgery
Lactate >1,
CI ≥ 2.5 L/min ScvO2 <70%
Oxygen YES NO NO
Delivery
MAP SVI < 35 ml/min SVI > 35 ml/min
90 60
Bi-spectral Index
40 2.0
70 Intubation Bowel/
Prep Incision Vasc 1.5
60 clamping/ Recovery
Anxiety Sleep Peritonel bleeding 0.5
MAP traction ICU MAC
Duration of surgery Modified from Mayer et al. Critical Care 2010, 14:R18
George 2014
Thursday, November 6, 14
Case
• A
man
underwent
closure
of
thoracic
wound
due
open
chest
drainage
caused
by
mediastinitis
for
2
weeks
in
the
ICU
Thursday, November 6, 14
CO ScvO2
5.0 74
Derived Value Calculator
Cl 4/10/2012SV
– 11:31:46 AM SVR
2.9 52 1014
l/min/m2 ml/b dyne-s/cm5
15 30 1899
% ml/b/m2 dyne-s-m2/cm5
9/8/2011
11:32:00 AM
Thursday, November 6, 14
CO ScvO2
5.0 74
Derived Value Calculator
4/10/2012 – 11:31:46 AM
Entries Derived
CVP = 4 mmHg DO2 = 658 ml O2/min
SpO2 = 100% DO2l = 432 ml O2/min/m2
PaO2 = 158 mmHg SVR = 1014 dyne-s/cm5
HGB = 10.3 g/dl SVRI = 1899 dyne-s/cm5
CO = 5.0 l/min
MAP = 62 mmHg
Return
9/8/2011
Alert Oximetry: SQI = 4 11:40:00 AM
Thursday, November 6, 14
• Dilakukan
loading
crystaloid
500cc
+
colloid
HES
130/0.4
sebanyak
250
cc
dalam
30
menit
Thursday, November 6, 14
CO ScvO2
7.5 74
Derived Value Calculator
Cl 4/10/2012SV
– 11:31:46 AM SVR
4.4 94 964
l/min/m2 ml/b dyne-s/cm5
9 55 1638
% ml/b/m2 dyne-s-m2/cm5
9/8/2011
11:57:00 AM
Thursday, November 6, 14
CO ScvO2
7.5 74
Derived Value Calculator
4/10/2012 – 11:31:46 AM
Entries Derived
CVP = 11 mmHg DO2 = 987 ml O2/min
SpO2 = 100% DO2l = 548 ml O2/min/m2
PaO2 = 158 mmHg SVR = 964 dyne-s/cm5
HGB = 10.3 g/dl SVRI = 1638 dyne-s/cm5
CO = 7.5 l/min
MAP = 86 mmHg
Return
9/8/2012
Alert Oximetry: SQI = 4 11:57:00 AM
Thursday, November 6, 14
Normal
heart
SVV
13% Line
of
reference
Stroke
Volume
LVEDV (mL)
Preload
Thursday, November 6, 14
Normal
heart
SVV
13% Line
of
reference
SVV
Stroke
Volume
15 %
LVEDV (mL)
Preload
Thursday, November 6, 14
Normal
heart
SVV Preload-‐independence:
If
CO
and
BP
low
à
no
more
9
% fluid,
need
vasoactive
SVV
13% Line
of
reference
SVV
Stroke
Volume
15 %
Preload-‐dependence:
If
CO
or
BP
lowà
need
more
fluid
LVEDV (mL)
Preload
Thursday, November 6, 14
Anesthesia target:
Adequate of Depth Of Anesthesia with BiSpectral Index
(40-60)
Haemodynamic Goal directed Therapy:
- Monitoring:
- Preload static: CVP, PAOP, GEDI
- Preload dynamic: SVV, SV, CI, PVI
- Met +DO2/VO2: Lactate/ScvO2
- Intervention :
- Fluid+Inotrope target CI >4.5
- Vasopresor target MAP>65
- PRC target DO2I >600 , lactate<1, ScvO2 >70%
Thursday, November 6, 14
The perioperative oxygen cascade indicated
therapies
to prevent postoperative complications
3.
Cardiovascular
performance
(cardiac
output)
1.Contractility 3.Afterload
(heart rate and valvular function)
2.Preload (coronary blood flow)
Perioperative haemodynamic therapy, Mukhail Y. Kirov et al. Curr Op Crit Care 2010
Thursday, November 6, 14
Concept of Individualized Hemodynamic Optimization
3.
Cardiovascular
performance
(cardiac
output)
1.Contractility 3.Afterload
(heart rate and valvular function)
2.Preload (coronary blood flow)
Perioperative haemodynamic therapy, Mukhail Y. Kirov et al. Curr Op Crit Care 2010
Thursday, November 6, 14
Concept of Individualized Hemodynamic Optimization
3.
Cardiovascular
performance
(cardiac
output)
1.Contractility 3.Afterload
(heart rate and valvular function)
2.Preload (coronary blood flow)
Perioperative haemodynamic therapy, Mukhail Y. Kirov et al. Curr Op Crit Care 2010
Thursday, November 6, 14
Concept of Individualized Hemodynamic Optimization
1.Contractility 3.Afterload
(heart rate and valvular function)
2.Preload (coronary blood flow)
Perioperative haemodynamic therapy, Mukhail Y. Kirov et al. Curr Op Crit Care 2010
Thursday, November 6, 14
Concept of Individualized Hemodynamic Optimization
1.Contractility 3.Afterload
(heart rate and valvular function)
2.Preload (coronary blood flow)
Perioperative haemodynamic therapy, Mukhail Y. Kirov et al. Curr Op Crit Care 2010
Thursday, November 6, 14
Concept of Individualized Hemodynamic Optimization
1.Contractility 3.Afterload
(heart rate and valvular function)
2.Preload (coronary blood flow)
Perioperative haemodynamic therapy, Mukhail Y. Kirov et al. Curr Op Crit Care 2010
Thursday, November 6, 14
Concept of Individualized Hemodynamic Optimization
1.Contractility 3.Afterload
(heart rate and valvular function)
2.Preload (coronary blood flow)
Perioperative haemodynamic therapy, Mukhail Y. Kirov et al. Curr Op Crit Care 2010
Thursday, November 6, 14
Concept of Individualized Hemodynamic Optimization
1.Contractility 3.Afterload
(heart rate and valvular function)
2.Preload (coronary blood flow)
Perioperative haemodynamic therapy, Mukhail Y. Kirov et al. Curr Op Crit Care 2010
Thursday, November 6, 14
Concept of Individualized Hemodynamic Optimization
1.Contractility 3.Afterload
(heart rate and valvular function)
2.Preload (coronary blood flow)
Perioperative haemodynamic therapy, Mukhail Y. Kirov et al. Curr Op Crit Care 2010
Thursday, November 6, 14
Concept of Individualized Hemodynamic Optimization
Microvascular pressure (fluid load)(?)
Microcirculatory recruitmenr (vasodilator and
inhibitor of vasoconstriction)(?)
Rheology(anti-coagulant,antiaggregants)(?)
1.Contractility 3.Afterload
(heart rate and valvular function)
2.Preload (coronary blood flow)
Perioperative haemodynamic therapy, Mukhail Y. Kirov et al. Curr Op Crit Care 2010
Thursday, November 6, 14
Concept of Individualized Hemodynamic Optimization
Microvascular pressure (fluid load)(?) Microvascular permeability (attenuation
Microcirculatory recruitmenr (vasodilator and of tissue oedema (?)
inhibitor of vasoconstriction)(?) Blood purification (e.g. CVVH, inhibitors
Rheology(anti-coagulant,antiaggregants)(?) of cytokines and mediators (?)
1.Contractility 3.Afterload
(heart rate and valvular function)
2.Preload (coronary blood flow)
Perioperative haemodynamic therapy, Mukhail Y. Kirov et al. Curr Op Crit Care 2010
Thursday, November 6, 14
Hypovolemic
Shock in Trauma
Thursday, November 6, 14
Hypovolemic shock
Thursday, November 6, 14
Causes of Hypovolemic
Shock
• Loss of Blood
• Loss of Plasma
Thursday, November 6, 14
Pathophysiology of shock from
Macrocirculation to Microcirculation
myocardial depression
➡ systolic and diastolic function)
Microcirculation
myocardial damage
➡︎systolic and diastolic function
Macrocirculation
Thursday, November 6, 14
Pathophysiology of shock from
Macrocirculation to Microcirculation
myocardial depression
➡ systolic and diastolic function)
Microcirculation
myocardial damage
➡︎systolic and diastolic function
Macrocirculation
Thursday, November 6, 14
Diagnosing of Shock Types
Arterial hypotension
➡︎MAP
Kidney : oligouria
Tachycardia
Elevated Lactate
Thursday, November 6, 14
Diagnosing of Shock Types
Arterial hypotension
➡︎MAP
Kidney : oligouria
Tachycardia
Elevated Lactate
Thursday, November 6, 14
Diagnosing of Shock Types
Arterial hypotension
➡︎MAP
Kidney : oligouria
Tachycardia
Elevated Lactate
Thursday, November 6, 14
Diagnosing of Shock Types
Arterial hypotension
➡︎MAP
Kidney : oligouria
Tachycardia
Elevated Lactate
Thursday, November 6, 14
Diagnosing of Shock Types
Arterial hypotension
➡︎MAP
Kidney : oligouria
Tachycardia
Elevated Lactate
Thursday, November 6, 14
Diagnosing of Shock Types
Arterial hypotension
➡︎MAP
Kidney : oligouria
Tachycardia
Elevated Lactate
Thursday, November 6, 14
Diagnosing of Shock Types
Arterial hypotension
➡︎MAP
Kidney : oligouria
Normal or High
Tachycardia
Elevated Lactate
Thursday, November 6, 14
Diagnosing of Shock Types
Arterial hypotension
➡︎MAP
Kidney : oligouria
Normal or High
Tachycardia
Elevated Lactate
Thursday, November 6, 14
Diagnosing of Shock Types
Arterial hypotension
➡︎MAP
Kidney : oligouria
Normal or High
Tachycardia
Elevated Lactate
Distributive
Thursday, November 6, 14
Diagnosing of Shock Types
Arterial hypotension
➡︎MAP
Kidney : oligouria
Normal or High
Tachycardia
Elevated Lactate
Distributive
Thursday, November 6, 14
Diagnosing of Shock Types
Arterial hypotension
➡︎MAP
Kidney : oligouria
Normal or High Low
Tachycardia
Elevated Lactate
Distributive
Thursday, November 6, 14
Diagnosing of Shock Types
Arterial hypotension
➡︎MAP
Kidney : oligouria
Normal or High Low
Tachycardia
Elevated Lactate
Distributive
Thursday, November 6, 14
Diagnosing of Shock Types
Arterial hypotension
➡︎MAP
Kidney : oligouria
Normal or High Low
Tachycardia
Distributive
Thursday, November 6, 14
Diagnosing of Shock Types
Arterial hypotension
➡︎MAP
Kidney : oligouria
Normal or High Low
Tachycardia
Distributive
Thursday, November 6, 14
Diagnosing of Shock Types
Arterial hypotension
➡︎MAP
Kidney : oligouria
Normal or High Low
Tachycardia
Low
Distributive
Thursday, November 6, 14
Diagnosing of Shock Types
Arterial hypotension
➡︎MAP
Kidney : oligouria
Normal or High Low
Tachycardia
Low
Distributive
Thursday, November 6, 14
Diagnosing of Shock Types
Arterial hypotension
➡︎MAP
Kidney : oligouria
Normal or High Low
Tachycardia
Low
Distributive hypovolemic
Thursday, November 6, 14
Diagnosing of Shock Types
Arterial hypotension
➡︎MAP
Kidney : oligouria
Normal or High Low
Tachycardia
Low
Distributive hypovolemic
Thursday, November 6, 14
Diagnosing of Shock Types
Arterial hypotension
➡︎MAP
Kidney : oligouria
Normal or High Low
Tachycardia
Low High
Distributive hypovolemic
Thursday, November 6, 14
Diagnosing of Shock Types
Arterial hypotension
➡︎MAP
Kidney : oligouria
Normal or High Low
Tachycardia
Low High
Distributive hypovolemic
Thursday, November 6, 14
Diagnosing of Shock Types
Arterial hypotension
➡︎MAP
Kidney : oligouria
Normal or High Low
Tachycardia
Low High
Thursday, November 6, 14
Diagnosing of Shock Types
Arterial hypotension
➡︎MAP
Kidney : oligouria
Normal or High Low
Tachycardia
Low High
Thursday, November 6, 14
Diagnosing of Shock Types
Arterial hypotension
➡︎MAP
Kidney : oligouria
Normal or High Low
Tachycardia
Low High
Thursday, November 6, 14
Diagnosing of Shock Types
Arterial hypotension
➡︎MAP
Kidney : oligouria
Normal or High Low
Tachycardia
Low High
Thursday, November 6, 14
Circulatory Shock Hemodynamic
Profile
+ ︎Base
Deficit
Thursday, November 6, 14
Circulatory Shock Hemodynamic
Profile
+ ︎Base
Deficit
Artiz ME. Circulatory shock;Vincent JL.Critical Care Medicine Textbook 6th ed, 2013
Thursday, November 6, 14
Circulatory Shock Hemodynamic
Profile
+ ︎Base
Deficit
Artiz ME. Circulatory shock;Vincent JL.Critical Care Medicine Textbook 6th ed, 2013
Thursday, November 6, 14
Pathophysiology in hemorrhagic shock
Sympatico-adrenegic reaction Central Venous Pressure ➡︎
Immunodepression
DIC Hyperfibrinolysis
Thursday, November 6, 14
Pathophysiology in hemorrhagic shock
Sympatico-adrenegic reaction Central Venous Pressure ➡︎
Immunodepression
DIC Hyperfibrinolysis
Thursday, November 6, 14
Pathophysiology in hemorrhagic shock
Sympatico-adrenegic reaction Central Venous Pressure ➡︎
Immunodepression
DIC Hyperfibrinolysis
Thursday, November 6, 14
Pathophysiology in hemorrhagic shock
Sympatico-adrenegic reaction Central Venous Pressure ➡︎
Immunodepression
DIC Hyperfibrinolysis
Thursday, November 6, 14
Pathophysiology in hemorrhagic shock
Sympatico-adrenegic reaction Central Venous Pressure ➡︎
Immunodepression
DIC Hyperfibrinolysis
Thursday, November 6, 14
Pathophysiology in hemorrhagic shock
Sympatico-adrenegic reaction Central Venous Pressure ➡︎
Immunodepression Hypothermia
DIC Hyperfibrinolysis
Thursday, November 6, 14
Pathophysiology in hemorrhagic shock
Sympatico-adrenegic reaction Central Venous Pressure ➡︎
Immunodepression Hypothermia
DIC Hyperfibrinolysis
Thursday, November 6, 14
Pathophysiology in hemorrhagic shock
Sympatico-adrenegic reaction Central Venous Pressure ➡︎
Immunodepression Hypothermia
DIC Hyperfibrinolysis
Multiple Organ Failure
J Trauma. 2004;57:898 –912.
Thursday, November 6, 14
Oxygen debt - repayment in
hemorrhagic shock
Lactate (mmol/L)
Time from start hemorrhage (min)
Siegel JH, Fabian M, Smith JA, Kingston EP, Steele KA, Wells MR: Oxygen debt criteria
quantify the effectiveness of early partial resuscitation after hypovolemic hemorrhagic shock.
J Trauma 54:862Y880, 2003
Thursday, November 6, 14
Oxygen debt - repayment in
hemorrhagic shock
Hemorrhage
Lactate (mmol/L)
Time from start hemorrhage (min)
Siegel JH, Fabian M, Smith JA, Kingston EP, Steele KA, Wells MR: Oxygen debt criteria
quantify the effectiveness of early partial resuscitation after hypovolemic hemorrhagic shock.
J Trauma 54:862Y880, 2003
Thursday, November 6, 14
Oxygen debt - repayment in
hemorrhagic shock
Partial
Resuscitation
Hemorrhage
Lactate (mmol/L)
Time from start hemorrhage (min)
Siegel JH, Fabian M, Smith JA, Kingston EP, Steele KA, Wells MR: Oxygen debt criteria
quantify the effectiveness of early partial resuscitation after hypovolemic hemorrhagic shock.
J Trauma 54:862Y880, 2003
Thursday, November 6, 14
Oxygen debt - repayment in
hemorrhagic shock
Partial
Resuscitation
Hemorrhage
2 hours delay
Lactate (mmol/L)
Time from start hemorrhage (min)
Siegel JH, Fabian M, Smith JA, Kingston EP, Steele KA, Wells MR: Oxygen debt criteria
quantify the effectiveness of early partial resuscitation after hypovolemic hemorrhagic shock.
J Trauma 54:862Y880, 2003
Thursday, November 6, 14
Oxygen debt - repayment in
hemorrhagic shock
Partial
Resuscitation
Hemorrhage
2 hours delay
Lactate (mmol/L)
O2 Debt
Siegel JH, Fabian M, Smith JA, Kingston EP, Steele KA, Wells MR: Oxygen debt criteria
quantify the effectiveness of early partial resuscitation after hypovolemic hemorrhagic shock.
J Trauma 54:862Y880, 2003
Thursday, November 6, 14
Oxygen debt - repayment in
hemorrhagic shock
Partial
Resuscitation
Hemorrhage
2 hours delay
Lactate (mmol/L)
O2 Debt
Lactate
Siegel JH, Fabian M, Smith JA, Kingston EP, Steele KA, Wells MR: Oxygen debt criteria
quantify the effectiveness of early partial resuscitation after hypovolemic hemorrhagic shock.
J Trauma 54:862Y880, 2003
Thursday, November 6, 14
Oxygen debt - repayment in
hemorrhagic shock
Partial
Resuscitation
Hemorrhage
2 hours delay
Base Deficit
Lactate (mmol/L)
O2 Debt
Lactate
Siegel JH, Fabian M, Smith JA, Kingston EP, Steele KA, Wells MR: Oxygen debt criteria
quantify the effectiveness of early partial resuscitation after hypovolemic hemorrhagic shock.
J Trauma 54:862Y880, 2003
Thursday, November 6, 14
Oxygen debt - repayment in
hemorrhagic shock
Partial Full
Resuscitation Resuscitation
Hemorrhage
2 hours delay
Base Deficit
Lactate (mmol/L)
O2 Debt
Lactate
Siegel JH, Fabian M, Smith JA, Kingston EP, Steele KA, Wells MR: Oxygen debt criteria
quantify the effectiveness of early partial resuscitation after hypovolemic hemorrhagic shock.
J Trauma 54:862Y880, 2003
Thursday, November 6, 14
Stages
of
Hemorrhagic
Shock
Microcircula,on Macrocircula,on
Thursday, November 6, 14
Stages
of
Hemorrhagic
Shock
Microcircula,on Macrocircula,on
Thursday, November 6, 14
Stages
of
Hemorrhagic
Shock
Microcircula,on Macrocircula,on
Thursday, November 6, 14
Stages
of
Hemorrhagic
Shock
Microcircula,on Macrocircula,on
Thursday, November 6, 14
Stages
of
Hemorrhagic
Shock
Microcircula,on Macrocircula,on
Thursday, November 6, 14
Stages
of
Hemorrhagic
Shock
Microcircula,on Macrocircula,on
Thursday, November 6, 14
Stages
of
Hemorrhagic
Shock
Microcircula,on Macrocircula,on
Thursday, November 6, 14
Stages
of
Hemorrhagic
Shock
Microcircula,on Macrocircula,on
Thursday, November 6, 14
Stages
of
Hemorrhagic
Shock
Microcircula,on Macrocircula,on
ia
sox
Dy
ck
-‐
Thursday, November 6, 14
Stages
of
Hemorrhagic
Shock
Microcircula,on Macrocircula,on
ia
sox
Dy
ck
-‐
O2 Extrac(on
Thursday, November 6, 14
Stages
of
Hemorrhagic
Shock
Microcircula,on Macrocircula,on
ia
sox
SvO2-‐ScvO2
Dy
ck
-‐
O2 Extrac(on
Thursday, November 6, 14
Stages
of
Hemorrhagic
Shock
Microcircula,on Macrocircula,on
ia
sox
SvO2-‐ScvO2
Dy
ck
-‐
O2 Extrac(on
Lactate
Base
Deficit
Hypoperfusion
begins:
best
5me
for
interven5on
like
supranormal
DO2
or
decreased
VO2
(demand)
ASAP
Thursday, November 6, 14
Stages
of
Hemorrhagic
Shock
Microcircula,on Macrocircula,on
ia
sox
SvO2-‐ScvO2
Dy
ck
-‐
O2 Extrac(on
Lactate
Base
Deficit
Hypoperfusion
begins:
best
5me
for
interven5on
like
too
late
for
interven,on:
hypotension
and
supranormal
DO2
or
decreased
VO2
(demand)
ASAP
cell
damage
was
already
occured
Thursday, November 6, 14
(early) Goal Directed Oxygen Balance in
Resuscitation hypovolemic shock
Microcirculation
Microcirculation
Endpoints of
resuscitation
Trzeciak, Rivers, Critical Care 2005,9(suppl 4):S20-S26
Thursday, November 6, 14
Preload assesment
Thursday, November 6, 14
Fluid challenge
Weil MH, Henning RJ: New concepts in the diagnosis and fluid treatment of
circulatory shock. Anesth Analg 1979;S8:124
12 14 50 ml/mnt
↑ =2 ↑ =3 Repeat
10 cm H20 = 7.3 mm Hg. CVP, central venous pressure; PAOP, pulmonary artery occlusion pressure
Hypovolemic shock; Parillo and Delinger, Critical Care Medicine Textbook, 2008
Thursday, November 6, 14
• Moderate level of evidence suggests that the IVC diameter is consistently low in
hypovolemic status when compared with euvolemic
Thursday, November 6, 14
• Meta-analysis of prospective studies reporting sonographic measurement of IVC
diameter and its relationship with volume status suggest its potential usability in
guiding fluid resuscitation in adult ED population under spontaneous ventilation
Thursday, November 6, 14
• Meta-analysis of prospective studies reporting sonographic measurement of IVC
diameter and its relationship with volume status suggest its potential usability in
guiding fluid resuscitation in adult ED population under spontaneous ventilation
Thursday, November 6, 14
During emergency department resuscitation, a decline in PetCO2 correlates with
decreases in noninvasive CO in emergently intubated trauma patients.
Decreasing PetCO2 and declining NICOM CO are associated with
hemodynamic instability, hemorrhage, abnormal pupils, and death.
Thursday, November 6, 14
The study indicates that NICOM CO and End-Tidal CO2
values are clinically discriminate the progressive of major
blood loss
Thursday, November 6, 14
Shock Classification in Trauma
Education of ATLS 2008
Thursday, November 6, 14
Shock Classification in Trauma
Education of ATLS 2008
Thursday, November 6, 14
Shock Classification in Trauma
Education of ATLS 2008
Thursday, November 6, 14
Shock Classification in Trauma
Education of ATLS 2008
Thursday, November 6, 14
Fluid Resuscitation
Permissive Hypotension and Hemorrhagic Shock
80%
60%
40%
20%
0%
Thursday, November 6, 14
Prehospital Hypotension and Outcome
in Trauma
• Register of Ann Arbor Seattle USA 19 409 patients 2373 hypotension
70.0000 Mortality
Blunt
Penetrating 52.5000
35.0000
17.5000
0
120 + 120-90 90-60 60-0 Sistolic Arterial Pressure
Thursday, November 6, 14
Permissive Hypotension for
Uncontrolled Hemorrhage
Thursday, November 6, 14
Thursday, November 6, 14
Thursday, November 6, 14
Thursday, November 6, 14
Thursday, November 6, 14
Shock Classification in Trauma
Education of ATLS 2008
?
Estimated Blood Loss and Transfusion based on
Patient’s Initial Presentation and vitals sign
Thursday, November 6, 14
Thursday, November 6, 14
Thursday, November 6, 14
Thursday, November 6, 14
Thursday, November 6, 14
Thursday, November 6, 14
Thursday, November 6, 14
Thursday, November 6, 14
Thursday, November 6, 14
A New Proposed Classification Using
Tissue Oxygenation Parameter
Thursday, November 6, 14
A New Proposed Classification Using
Tissue Oxygenation Parameter
Thursday, November 6, 14
Thursday, November 6, 14
Thursday, November 6, 14
Thursday, November 6, 14
Thursday, November 6, 14
Thursday, November 6, 14
Thursday, November 6, 14
Hypoperfusion occurs despite normal blood pressure
Thursday, November 6, 14
Parameter of anaerobic metabolism more reliable
detecting hypoperfusion than Blood Pressure
Thursday, November 6, 14
Parameter of anaerobic metabolism more reliable
detecting hypoperfusion than Blood Pressure
Thursday, November 6, 14
Thursday, November 6, 14
Thursday, November 6, 14
Thursday, November 6, 14
Thursday, November 6, 14
Thursday, November 6, 14
Thursday, November 6, 14
Goal-directed therapy
Thursday, November 6, 14
Guidelines for Treatment of
Hypovolemic Shock
1. Insert large-bore intravenous catheter; perform laboratory investigations
(crossmatching, Hb, Ht, Tr, Elecrolyte, ABG and pH, lactate, coagulation, transaminase
and albumin. Watch for need to supply oxygen, intubation, or artificial ventilation
Hypovolemic shock; Parillo and Delinger, Critical Care Medicine Textbook, 2014
Thursday, November 6, 14
Supranormal value
Thursday, November 6, 14
Vincent protocol, 2005
Pinsky MR, Vincent JL: Let us use the PAC correctly and only when we need it. Crit Care Med 2005;33:1119-1122
Thursday, November 6, 14
Vincent protocol, 2005
SVO2
Normal
(≥79%)
Pinsky MR, Vincent JL: Let us use the PAC correctly and only when we need it. Crit Care Med 2005;33:1119-1122
Thursday, November 6, 14
Vincent protocol, 2005
SVO2
Normal Low
(≥79%) (<70%)
pCO2 gap<6
Blood Lactate
Pinsky MR, Vincent JL: Let us use the PAC correctly and only when we need it. Crit Care Med 2005;33:1119-1122
Thursday, November 6, 14
Vincent protocol, 2005
SVO2
Normal Low
(≥79%) (<70%)
pCO2 gap<6
Blood Lactate
SaO2 Low SaO2 Normal (95%)
(Hypoxemia) (↑ O2ER)
Pinsky MR, Vincent JL: Let us use the PAC correctly and only when we need it. Crit Care Med 2005;33:1119-1122
Thursday, November 6, 14
Vincent protocol, 2005
SVO2
Normal Low
(≥79%) (<70%)
pCO2 gap<6
Blood Lactate
SaO2 Low SaO2 Normal (95%)
(Hypoxemia) (↑ O2ER)
Oxgen therapy
↑ PEEP
Pinsky MR, Vincent JL: Let us use the PAC correctly and only when we need it. Crit Care Med 2005;33:1119-1122
Thursday, November 6, 14
Vincent protocol, 2005
SVO2
Normal Low
(≥79%) (<70%)
pCO2 gap<6
Blood Lactate
SaO2 Low SaO2 Normal (95%)
(Hypoxemia) (↑ O2ER)
Oxgen therapy
↑ PEEP Cardiac Output
Pinsky MR, Vincent JL: Let us use the PAC correctly and only when we need it. Crit Care Med 2005;33:1119-1122
Thursday, November 6, 14
Vincent protocol, 2005
SVO2
Normal Low
(≥79%) (<70%)
pCO2 gap<6
Blood Lactate
SaO2 Low SaO2 Normal (95%)
(Hypoxemia) (↑ O2ER)
Oxgen therapy
↑ PEEP Cardiac Output
High Low
(>2.5 L/min/m2) (<2.5 L/min/m2)
Pinsky MR, Vincent JL: Let us use the PAC correctly and only when we need it. Crit Care Med 2005;33:1119-1122
Thursday, November 6, 14
Vincent protocol, 2005
SVO2
Normal Low
(≥79%) (<70%)
pCO2 gap<6
Blood Lactate
SaO2 Low SaO2 Normal (95%)
(Hypoxemia) (↑ O2ER)
Oxgen therapy
↑ PEEP Cardiac Output
High Low
(>2.5 L/min/m2) (<2.5 L/min/m2)
Hemoglobin
>8 g/dL
Stress, anxiety, pain
(High VO2)
Pinsky MR, Vincent JL: Let us use the PAC correctly and only when we need it. Crit Care Med 2005;33:1119-1122
Thursday, November 6, 14
Vincent protocol, 2005
SVO2
Normal Low
(≥79%) (<70%)
pCO2 gap<6
Blood Lactate
SaO2 Low SaO2 Normal (95%)
(Hypoxemia) (↑ O2ER)
Oxgen therapy
↑ PEEP Cardiac Output
High Low
(>2.5 L/min/m2) (<2.5 L/min/m2)
Hemoglobin
>8 g/dL
Stress, anxiety, pain
(High VO2)
Analgesic
Sedation
Pinsky MR, Vincent JL: Let us use the PAC correctly and only when we need it. Crit Care Med 2005;33:1119-1122
Thursday, November 6, 14
Vincent protocol, 2005
SVO2
Normal Low
(≥79%) (<70%)
pCO2 gap<6
Blood Lactate
SaO2 Low SaO2 Normal (95%)
(Hypoxemia) (↑ O2ER)
Oxgen therapy
↑ PEEP Cardiac Output
High Low
(>2.5 L/min/m2) (<2.5 L/min/m2)
Hemoglobin
Analgesic
Sedation
Pinsky MR, Vincent JL: Let us use the PAC correctly and only when we need it. Crit Care Med 2005;33:1119-1122
Thursday, November 6, 14
Vincent protocol, 2005
SVO2
Normal Low
(≥79%) (<70%)
pCO2 gap<6
Blood Lactate
SaO2 Low SaO2 Normal (95%)
(Hypoxemia) (↑ O2ER)
Oxgen therapy
↑ PEEP Cardiac Output
High Low
(>2.5 L/min/m2) (<2.5 L/min/m2)
Hemoglobin PAOP-CVP
Analgesic Blood
Sedation transfusion
Pinsky MR, Vincent JL: Let us use the PAC correctly and only when we need it. Crit Care Med 2005;33:1119-1122
Thursday, November 6, 14
Vincent protocol, 2005
SVO2
Normal Low
(≥79%) (<70%)
pCO2 gap<6
Blood Lactate
SaO2 Low SaO2 Normal (95%)
(Hypoxemia) (↑ O2ER)
Oxgen therapy
↑ PEEP Cardiac Output
High Low
(>2.5 L/min/m2) (<2.5 L/min/m2)
Hemoglobin PAOP-CVP
Analgesic Blood
Dobutamine
Sedation transfusion
Pinsky MR, Vincent JL: Let us use the PAC correctly and only when we need it. Crit Care Med 2005;33:1119-1122
Thursday, November 6, 14
Vincent protocol, 2005
SVO2
Normal Low
(≥79%) (<70%)
pCO2 gap<6
Blood Lactate
SaO2 Low SaO2 Normal (95%)
(Hypoxemia) (↑ O2ER)
Oxgen therapy
↑ PEEP Cardiac Output
High Low
(>2.5 L/min/m2) (<2.5 L/min/m2)
Hemoglobin PAOP-CVP
Analgesic Blood
Dobutamine Fluid challenge
Sedation transfusion
Pinsky MR, Vincent JL: Let us use the PAC correctly and only when we need it. Crit Care Med 2005;33:1119-1122
Thursday, November 6, 14
Vincent protocol, 2005
SVO2
Normal Low
(≥79%) (<70%)
pCO2 gap<6
Blood Lactate
SaO2 Low SaO2 Normal (95%)
(Hypoxemia) (↑ O2ER)
Oxgen therapy
↑ PEEP Cardiac Output
High Low
(>2.5 L/min/m2) (<2.5 L/min/m2)
SVV-PPV
Hemoglobin PAOP-CVP IVC colapsibility
Analgesic Blood
Dobutamine Fluid challenge
Sedation transfusion
Pinsky MR, Vincent JL: Let us use the PAC correctly and only when we need it. Crit Care Med 2005;33:1119-1122
Thursday, November 6, 14
Pearce protocol, 2005
Pearse RM, Dawson D, Fawcett J, et al: Early goal-directed therapy after major surgery reduces complications and
duration of hospital stay. Crit Care 2005;9:687-693
Thursday, November 6, 14
Trauma/hemorrhage
Elevated lactate
Supplemental O2 ± ETI
with mech ventilation (if
necessary) Begin fluid resuscitation (initial bolus of
Target SaO2 of ≥ 95% at least 20 ml/kg crystalloid, to be
continued with colloids, red cell
concentrates and coagulation factors
management protocol
Filling pressure
<8 mmHg Insert
Fluid boluses CVP or PA
Cath
Filling pressure
> 8 mmHg
Dobutamine/ < 70%
Dopamine ScvO2*
< 70%
MAP < 65
Vasopressor (norepinephrine
MAP
or dopamine prefered)
MAP ≥ 65
*If PAC is used a mixed venous Os sat is NO
ALL Goals
an acceptable surrogate, and 65% would
achieved?
be the target
Hypovolemic shock; Parillo and Delinger, Critical Care Medicine Textbook, 2014
Thursday, November 6, 14
Trauma/hemorrhage
Elevated lactate
Supplemental O2 ± ETI
with mech ventilation (if
necessary) Begin fluid resuscitation (initial bolus of
Target SaO2 of ≥ 95% at least 20 ml/kg crystalloid, to be
continued with colloids, red cell
concentrates and coagulation factors
management protocol
Filling pressure
<8 mmHg Insert
Fluid boluses CVP or PA
Cath
Filling pressure
> 8 mmHg
Dobutamine/ < 70%
Dopamine ScvO2*
< 70%
MAP < 65
Vasopressor (norepinephrine
MAP
or dopamine prefered)
MAP ≥ 65
*If PAC is used a mixed venous Os sat is NO
ALL Goals
an acceptable surrogate, and 65% would
achieved?
be the target
Hypovolemic shock; Parillo and Delinger, Critical Care Medicine Textbook, 2014
Thursday, November 6, 14
Trauma/hemorrhage
Elevated lactate
Supplemental O2 ± ETI
with mech ventilation (if
necessary) Begin fluid resuscitation (initial bolus of
Target SaO2 of ≥ 95% at least 20 ml/kg crystalloid, to be
continued with colloids, red cell
concentrates and coagulation factors
management protocol
Filling pressure
<8 mmHg Insert
Fluid boluses CVP or PA
Cath
Filling pressure
> 8 mmHg
Dobutamine/ < 70%
Dopamine ScvO2*
< 70%
MAP < 65
Vasopressor (norepinephrine
MAP
or dopamine prefered)
MAP ≥ 65
*If PAC is used a mixed venous Os sat is NO
ALL Goals
an acceptable surrogate, and 65% would
achieved?
be the target
Hypovolemic shock; Parillo and Delinger, Critical Care Medicine Textbook, 2014
Thursday, November 6, 14
Trauma/hemorrhage
Elevated lactate
Supplemental O2 ± ETI
with mech ventilation (if
necessary) Begin fluid resuscitation (initial bolus of
Target SaO2 of ≥ 95% at least 20 ml/kg crystalloid, to be
continued with colloids, red cell
concentrates and coagulation factors
management protocol
Filling pressure
<8 mmHg Insert
Fluid boluses CVP or PA
Cath
Filling pressure
> 8 mmHg
Dobutamine/ < 70%
Dopamine ScvO2*
< 70%
MAP < 65
Vasopressor (norepinephrine
MAP
or dopamine prefered)
MAP ≥ 65
*If PAC is used a mixed venous Os sat is NO
ALL Goals
an acceptable surrogate, and 65% would
achieved?
be the target
Hypovolemic shock; Parillo and Delinger, Critical Care Medicine Textbook, 2014
Thursday, November 6, 14
Trauma/hemorrhage
Elevated lactate
Supplemental O2 ± ETI
with mech ventilation (if
necessary) Begin fluid resuscitation (initial bolus of
Target SaO2 of ≥ 95% at least 20 ml/kg crystalloid, to be
continued with colloids, red cell
concentrates and coagulation factors
management protocol
Filling pressure
<8 mmHg Insert
Fluid boluses CVP or PA
Cath
Filling pressure
> 8 mmHg
Dobutamine/ < 70%
Dopamine ScvO2*
< 70%
MAP < 65
Vasopressor (norepinephrine
MAP
or dopamine prefered)
MAP ≥ 65
*If PAC is used a mixed venous Os sat is NO
ALL Goals
an acceptable surrogate, and 65% would
achieved?
be the target
Hypovolemic shock; Parillo and Delinger, Critical Care Medicine Textbook, 2014
Thursday, November 6, 14
Trauma/hemorrhage
Elevated lactate
Supplemental O2 ± ETI
with mech ventilation (if
necessary) Begin fluid resuscitation (initial bolus of
Target SaO2 of ≥ 95% at least 20 ml/kg crystalloid, to be
continued with colloids, red cell
concentrates and coagulation factors
management protocol
Filling pressure
<8 mmHg Insert
Fluid boluses CVP or PA
Cath
Filling pressure
> 8 mmHg
Dobutamine/ < 70%
Dopamine ScvO2*
< 70%
MAP < 65
Vasopressor (norepinephrine
MAP
or dopamine prefered)
MAP ≥ 65
*If PAC is used a mixed venous Os sat is NO
ALL Goals
an acceptable surrogate, and 65% would
achieved?
be the target
Hypovolemic shock; Parillo and Delinger, Critical Care Medicine Textbook, 2014
Thursday, November 6, 14
Trauma/hemorrhage
Elevated lactate
Supplemental O2 ± ETI
with mech ventilation (if
necessary) Begin fluid resuscitation (initial bolus of
Target SaO2 of ≥ 95% at least 20 ml/kg crystalloid, to be
continued with colloids, red cell
concentrates and coagulation factors
management protocol
Filling pressure
<8 mmHg Insert
Fluid boluses CVP or PA
Cath
Filling pressure
> 8 mmHg
Dobutamine/ < 70%
Dopamine ScvO2*
< 70%
MAP < 65
Vasopressor (norepinephrine
MAP
or dopamine prefered)
MAP ≥ 65
*If PAC is used a mixed venous Os sat is NO
ALL Goals
an acceptable surrogate, and 65% would
achieved?
be the target
Hypovolemic shock; Parillo and Delinger, Critical Care Medicine Textbook, 2014
Thursday, November 6, 14
Trauma/hemorrhage
Elevated lactate
Supplemental O2 ± ETI
with mech ventilation (if
necessary) Begin fluid resuscitation (initial bolus of
Target SaO2 of ≥ 95% at least 20 ml/kg crystalloid, to be
continued with colloids, red cell
concentrates and coagulation factors
management protocol
Filling pressure
<8 mmHg Insert
Fluid boluses CVP or PA
Cath
Filling pressure
> 8 mmHg
Dobutamine/ < 70%
Dopamine ScvO2*
< 70%
MAP < 65
Vasopressor (norepinephrine
MAP
or dopamine prefered)
MAP ≥ 65
*If PAC is used a mixed venous Os sat is NO
ALL Goals
an acceptable surrogate, and 65% would
achieved?
be the target
Hypovolemic shock; Parillo and Delinger, Critical Care Medicine Textbook, 2014
Thursday, November 6, 14
Trauma/hemorrhage
Elevated lactate
Supplemental O2 ± ETI
with mech ventilation (if
necessary) Begin fluid resuscitation (initial bolus of
Target SaO2 of ≥ 95% at least 20 ml/kg crystalloid, to be
continued with colloids, red cell
concentrates and coagulation factors
management protocol
Filling pressure
<8 mmHg Insert
Fluid boluses CVP or PA
Cath
Filling pressure
> 8 mmHg
Dobutamine/ < 70%
Dopamine ScvO2*
< 70%
MAP < 65
Vasopressor (norepinephrine
MAP
or dopamine prefered)
MAP ≥ 65
*If PAC is used a mixed venous Os sat is NO
ALL Goals
an acceptable surrogate, and 65% would
achieved?
be the target
Hypovolemic shock; Parillo and Delinger, Critical Care Medicine Textbook, 2014
Thursday, November 6, 14
Trauma/hemorrhage
Elevated lactate
Supplemental O2 ± ETI
with mech ventilation (if
necessary) Begin fluid resuscitation (initial bolus of
Target SaO2 of ≥ 95% at least 20 ml/kg crystalloid, to be
continued with colloids, red cell
concentrates and coagulation factors
management protocol
Filling pressure
<8 mmHg Insert
Fluid boluses CVP or PA
Cath
Filling pressure
> 8 mmHg
Dobutamine/ < 70%
Dopamine ScvO2*
< 70%
MAP < 65
Vasopressor (norepinephrine
MAP
or dopamine prefered)
MAP ≥ 65
*If PAC is used a mixed venous Os sat is NO
ALL Goals
an acceptable surrogate, and 65% would
achieved?
be the target
Hypovolemic shock; Parillo and Delinger, Critical Care Medicine Textbook, 2014
Thursday, November 6, 14
Trauma/hemorrhage
Elevated lactate
Supplemental O2 ± ETI
with mech ventilation (if
necessary) Begin fluid resuscitation (initial bolus of
Target SaO2 of ≥ 95% at least 20 ml/kg crystalloid, to be
continued with colloids, red cell
concentrates and coagulation factors
management protocol
Filling pressure
<8 mmHg Insert
Fluid boluses CVP or PA
Cath
Filling pressure
> 8 mmHg
Dobutamine/ < 70%
Dopamine ScvO2*
< 70%
MAP < 65
Vasopressor (norepinephrine
MAP
or dopamine prefered)
MAP ≥ 65
*If PAC is used a mixed venous Os sat is NO
ALL Goals
an acceptable surrogate, and 65% would
achieved?
be the target
Hypovolemic shock; Parillo and Delinger, Critical Care Medicine Textbook, 2014
Thursday, November 6, 14
Trauma/hemorrhage
Elevated lactate
Supplemental O2 ± ETI
with mech ventilation (if
necessary) Begin fluid resuscitation (initial bolus of
Target SaO2 of ≥ 95% at least 20 ml/kg crystalloid, to be
continued with colloids, red cell
concentrates and coagulation factors
management protocol
Filling pressure
<8 mmHg Insert
Fluid boluses CVP or PA
Cath
Filling pressure
> 8 mmHg
Dobutamine/ < 70%
Dopamine ScvO2*
< 70%
MAP < 65
Vasopressor (norepinephrine
MAP
or dopamine prefered)
MAP ≥ 65
*If PAC is used a mixed venous Os sat is NO
ALL Goals
an acceptable surrogate, and 65% would
achieved?
be the target
Hypovolemic shock; Parillo and Delinger, Critical Care Medicine Textbook, 2014
Thursday, November 6, 14
Fluid Resuscitation
in Trauma Patients
Thursday, November 6, 14
In the 1950s and 1960s much trauma
research focused on high volume
resuscitation
In the 1980s, the concept of limited fluid
resuscitation returned. Animal models
focused on uncontrolled hemorrhage, a
more realistic model.
Thursday, November 6, 14
Conclusion; For hypotensive patients with
penetrating torso injuries, delay of aggresive fluid
resuscitation until operative intervention
improves the outcome
Thursday, November 6, 14
Case
Thursday, November 6, 14
• The patient’s initial vital signs are: heart rate of 140
beats per minute, blood pressure of 80/50 mm Hg,
respiratory rate of 20 breaths per minute, temperature
of 97°F (36.1°C), and SpO2 of 100% on room air.
Thursday, November 6, 14
What is the
suspected injury ?
Thursday, November 6, 14
What is the first
resuscitation action
should be done?
Thursday, November 6, 14
Trias of death in trauma
Thursday, November 6, 14
Trias of death in trauma
Thursday, November 6, 14
• Airway -Ventilation : O2
FM 6lt/min
• Circulation : 2 large
bore IV, fluid
resuscitation 1-2 litres
• Crystalloid or colloid ?
• Transfusion ?
Thursday, November 6, 14
What is the laboratory
examination required ?
Thursday, November 6, 14
• Complete blood count
Thursday, November 6, 14
Lab findings
• Hb 6.0/ Ht 15/ Leu 12.000/ Plt 70.000
Thursday, November 6, 14
21th century:
A New Approch in Trauma Resuscitation
Thursday, November 6, 14
Flowchart of initial management of traumatic hemorrhagic shock
Bouglé et al. Annals of Intensive Care 2013, 3:1
Thursday, November 6, 14
Flowchart of initial management of traumatic hemorrhagic shock
Bouglé et al. Annals of Intensive Care 2013, 3:1
Thursday, November 6, 14
Fluid Resuscitation based on
Classes of shock by ATLS
Thursday, November 6, 14
Fluid Resuscitation based on
Classes of shock by ATLS
Crystalloids
Thursday, November 6, 14
Fluid Resuscitation based on
Classes of shock by ATLS
Crystalloids
Colloids
Thursday, November 6, 14
Fluid Resuscitation based on
Classes of shock by ATLS
Crystalloids
Colloids
Blood transfusions
Thursday, November 6, 14
Fluid option
• Blood and components
• Crystalloid
• Colloid
• Hypertonic solution
Thursday, November 6, 14
Isotonic crystalloids
••Advantages
Cheap
• Easy to store and warm
• Established safety
• Predictable rise in cardiac output
••
Disadvantages14
Large volumes needed
• Dilutional coagulopathy
• Increase cytokine activation7
• No oxygen carrying capacity
• May Increase ICP
Thursday, November 6, 14
Composition of IV
Crystalloid
Na Cl K Ca Buffer pH
Plasma 141 103 4-5 5 Bicarb 7.4
0.9%NS 154 154 ---- ---- ---- 5.7
LR 131 111 2 3 Lactate 6.4
Thursday, November 6, 14
LR vs NS
• Patients undergoing aortic aneurysm repair
• NS
• More volume (~500-1000ml)
• Hyperchloremic acidosis
• Dilutional coagulopathy
Thursday, November 6, 14
LR vs NS
• Conclusion
•
No mortality difference
• LR
• Lower overall volume
• More buffering capacity
• NS
• Hyperchloremia acidosis
• Dilutional coagulopathy
• Probably no difference for prehospital or early fluid resuscitation.
Thursday, November 6, 14
Colloids
• Proposed Benefits
• Smaller volume
• Less pulmonary edema
• Stays in the intravascular space
• Quicker return to normal
hemodynamics
• Smaller package
• Antioxidant and antinflammatory effects
Thursday, November 6, 14
Colloids
• •Disadvantages
Transmission of diseases
• Increased bleeding
• Hypersensitivity reactions
• Renal failure
• Accumulation
• Taken up by RES
• Dose limit (20-33mL/kg)
• Cost
Thursday, November 6, 14
Hypertonic Saline
• Rapid plasma volume expansion
• Pull of fluid to vascular space secondary to increased
concentration gradient
• Decreases ICP
• Potential benefits in TBI patients
• Military use
• Weighs less
• 1 liter NS bag=2744 cm3 in volume and 1.1 kg
Thursday, November 6, 14
Hypertonic Saline
• Adverse effects
• Hyperosmolar coma
• Hypernatremia
• Seizures
• arrhythmias
• Tissue necrosis
• Allergic reactions
Thursday, November 6, 14
Hypertonic Saline
• Hypertonic saline
• 7.5% or 7.2%
Thursday, November 6, 14
Natural Colloids :
Albumin
• SAFE trial 2004 (N Engl J Med 2004)
•
Double blind RCT, 7000 pts, 16 ICUs, 18 month period
• 4% albumin v 0.9% normal saline
• First 4 days volume albumin to saline (1:1.4)
• No difference in 2 groups in 28 all day cause mortality
• Sub group analysis: difference between trauma and sepsis
patients
• RR of death pts with severe sepsis= 0.87
• Overall trauma mortality higher for albumin v saline (13.5%
v 10%)
• TBI increase in mortality
Thursday, November 6, 14
Bio-physiology of Colloids
Thursday, November 6, 14
Bio-physiology of Colloids
Thursday, November 6, 14
Crystalloid vs colloid
distribution
Fluids Plasma Interstitial Intracellular
Alb5% 1000
Expafusin 6% 1000
Poligeline 700 300
Dextran 40 1600 -260 -340
Dextran 70 1300 -130 -170
NaCl 0.9% 200 800
NaCl 1.8% 320 1280 -600
NaCl 0.45% 141 567 292
RL 200 800
D5% 83 333 583
Thursday, November 6, 14
Vasoactives
Thursday, November 6, 14
Flowchart of initial management of traumatic hemorrhagic shock
Bouglé et al. Annals of Intensive Care 2013, 3:1
Thursday, November 6, 14
Flowchart of initial management of traumatic hemorrhagic shock
Bouglé et al. Annals of Intensive Care 2013, 3:1
Thursday, November 6, 14
Baseline Characteristics Dopamine Norepinephrine
Thursday, November 6, 14
Baseline Characteristics Dopamine Norepinephrine
Thursday, November 6, 14
Result
• In summary, although the rate of death did not differ significantly between the group of
patients treated with dopamine and the group treated with norepinephrine, this study
raises serious concerns about dopamine, as compared with norepinephrine, was
associated with more arrhythmias and with an increased rate of death in the
subgroup of patients with cardiogenic shock
Thursday, November 6, 14
Transfusion
trigger
Thursday, November 6, 14
Transfusion guidelines
Thursday, November 6, 14
Thursday, November 6, 14
Thursday, November 6, 14
Thursday, November 6, 14
Thursday, November 6, 14
Fluid Choice and Blood for Resuscitation
Fluid Choice for Resuscitation in Trauma. Joachim Boldt, International TraumaCare (ITACCS).Vol. 18, No. 1, 2008
Thursday, November 6, 14
Fluid Choice and Blood for Resuscitation
Fluid Choice for Resuscitation in Trauma. Joachim Boldt, International TraumaCare (ITACCS).Vol. 18, No. 1, 2008
Thursday, November 6, 14
Fluid Choice and Blood for Resuscitation
Fluid Choice for Resuscitation in Trauma. Joachim Boldt, International TraumaCare (ITACCS).Vol. 18, No. 1, 2008
Thursday, November 6, 14
Fluid Choice and Blood for Resuscitation
Crystalloid +
colloid
Progressive laboratory assessment of hemoglobin level and hemostasis
Fluid Choice for Resuscitation in Trauma. Joachim Boldt, International TraumaCare (ITACCS).Vol. 18, No. 1, 2008
Thursday, November 6, 14
Fluid Choice and Blood for Resuscitation
Crystalloid +
colloid
Progressive laboratory assessment of hemoglobin level and hemostasis
Fluid Choice for Resuscitation in Trauma. Joachim Boldt, International TraumaCare (ITACCS).Vol. 18, No. 1, 2008
Thursday, November 6, 14
Fluid Choice and Blood for Resuscitation
Crystalloid +
colloid
Progressive laboratory assessment of hemoglobin level and hemostasis
Fluid Choice for Resuscitation in Trauma. Joachim Boldt, International TraumaCare (ITACCS).Vol. 18, No. 1, 2008
Thursday, November 6, 14
Fluid Choice and Blood for Resuscitation
Platelets
Crystalloid +
colloid
Progressive laboratory assessment of hemoglobin level and hemostasis
Fluid Choice for Resuscitation in Trauma. Joachim Boldt, International TraumaCare (ITACCS).Vol. 18, No. 1, 2008
Thursday, November 6, 14
How should the
coagulopathy of trauma
be managed?
Thursday, November 6, 14
Management of bleeding following major trauma: an
updated European guideline
Critical Care 2010
Thursday, November 6, 14
Management of bleeding following major trauma: an
updated European guideline
Critical Care 2010
I. Initial
II. Diagnosis and IV. Management of V. Tissue
resuscitation and III. Rapid control of
monitoring of bleeding and oxygenation, fluid
prevention of bleeding
bleeding coagulation and hypothermia
further bleeding
Thursday, November 6, 14
Management of bleeding following major trauma: an
updated European guideline
Critical Care 2010
I. Initial
II. Diagnosis and IV. Management of V. Tissue
resuscitation and III. Rapid control of
monitoring of bleeding and oxygenation, fluid
prevention of bleeding
bleeding coagulation and hypothermia
further bleeding
Coagulation
management
Thursday, November 6, 14
Management of bleeding following major trauma: an
updated European guideline
Critical Care 2010
I. Initial
II. Diagnosis and IV. Management of V. Tissue
resuscitation and III. Rapid control of
monitoring of bleeding and oxygenation, fluid
prevention of bleeding
bleeding coagulation and hypothermia
further bleeding
Coagulation
management
Coagulation support
Calcium
Fresh frozen plasma
Platelets
Fibrinogen or cryoprecipitate
Antifibrinolytic agents
Recombinant activated coagulation factor VII
Protrombin complex concentrate
Desmopressin
Antithrombin III
Thursday, November 6, 14
Management of bleeding following major trauma: an
updated European guideline
Critical Care 2010
I. Initial
II. Diagnosis and IV. Management of V. Tissue
resuscitation and III. Rapid control of
monitoring of bleeding and oxygenation, fluid
prevention of bleeding
bleeding coagulation and hypothermia
further bleeding
Thursday, November 6, 14
Flowchart of initial management of traumatic hemorrhagic shock
Bouglé et al. Annals of Intensive Care 2013, 3:1
Thursday, November 6, 14
Flowchart of initial management of traumatic hemorrhagic shock
Bouglé et al. Annals of Intensive Care 2013, 3:1
Thursday, November 6, 14
Flowchart of initial management of traumatic hemorrhagic shock
Bouglé et al. Annals of Intensive Care 2013, 3:1
Thursday, November 6, 14
Flowchart of initial management of traumatic hemorrhagic shock
Bouglé et al. Annals of Intensive Care 2013, 3:1
Thursday, November 6, 14
Management of bleeding following major trauma: an
updated European guideline
Critical Care 2010
I. Initial
II. Diagnosis and IV. Management of V. Tissue
resuscitation and III. Rapid control of
monitoring of bleeding and oxygenation, fluid
prevention of bleeding
bleeding coagulation and hypothermia
further bleeding
Thursday, November 6, 14
Management of bleeding following major trauma: an
updated European guideline
Critical Care 2010
I. Initial
II. Diagnosis and IV. Management of V. Tissue
resuscitation and III. Rapid control of
monitoring of bleeding and oxygenation, fluid
prevention of bleeding
bleeding coagulation and hypothermia
further bleeding
RESUSCITATION
Thursday, November 6, 14
Management of bleeding following major trauma: an
updated European guideline
Critical Care 2010
I. Initial
II. Diagnosis and IV. Management of V. Tissue
resuscitation and III. Rapid control of
monitoring of bleeding and oxygenation, fluid
prevention of bleeding
bleeding coagulation and hypothermia
further bleeding
VOLUME REPLACEMENT
A target systolic blood pressure of
80-100 mmHg should be employed RESUSCITATION
until major bleeding has been stopped
in the initial phase following trauma
without brain injury
Thursday, November 6, 14
Management of bleeding following major trauma: an
updated European guideline
Critical Care 2010
I. Initial
II. Diagnosis and IV. Management of V. Tissue
resuscitation and III. Rapid control of
monitoring of bleeding and oxygenation, fluid
prevention of bleeding
bleeding coagulation and hypothermia
further bleeding
VOLUME REPLACEMENT
A target systolic blood pressure of
80-100 mmHg should be employed RESUSCITATION
until major bleeding has been stopped
in the initial phase following trauma
without brain injury
FLUID THERAPY
Crystalloid should be applied initially to treat the
bleeding trauma patient. Hypertonic solutions may be
considered during initial treatment. The addition of
colloids may be considered within the prescribed
limits for each solution in haemodynamically unstable
patients.
Thursday, November 6, 14
Management of bleeding following major trauma: an
updated European guideline
Critical Care 2010
I. Initial
II. Diagnosis and IV. Management of V. Tissue
resuscitation and III. Rapid control of
monitoring of bleeding and oxygenation, fluid
prevention of bleeding
bleeding coagulation and hypothermia
further bleeding
VOLUME REPLACEMENT
A target systolic blood pressure of
80-100 mmHg should be employed RESUSCITATION
until major bleeding has been stopped
in the initial phase following trauma
without brain injury
FLUID THERAPY
Crystalloid should be applied initially to treat the
bleeding trauma patient. Hypertonic solutions may be
considered during initial treatment. The addition of
colloids may be considered within the prescribed
NORMOTHERMIA
limits for each solution in haemodynamically unstable
Early application of meassures to
patients.
reduce heat loss and warm the
hypothermic patient should be
employed to achieve and maintain
normothermia.
Thursday, November 6, 14
Management of bleeding following major trauma: an
updated European guideline
Critical Care 2010
I. Initial
II. Diagnosis and IV. Management of V. Tissue
resuscitation and III. Rapid control of
monitoring of bleeding and oxygenation, fluid
prevention of bleeding
bleeding coagulation and hypothermia
further bleeding
VOLUME REPLACEMENT
A target systolic blood pressure of
80-100 mmHg should be employed RESUSCITATION
until major bleeding has been stopped
in the initial phase following trauma
without brain injury
FLUID THERAPY
Crystalloid should be applied initially to treat the
bleeding trauma patient. Hypertonic solutions may be
considered during initial treatment. The addition of
colloids may be considered within the prescribed
NORMOTHERMIA
limits for each solution in haemodynamically unstable
Early application of meassures to ERYTHROCYTES
patients.
reduce heat loss and warm the Treatment should aim to
hypothermic patient should be achieve a target Hb of
employed to achieve and maintain 7-9 g/dl.
normothermia.
Thursday, November 6, 14
The main pathophysiological mechanisms involved in
acute traumatic coagulopathy and transfusion strategy
Thursday, November 6, 14
The main pathophysiological mechanisms involved in
acute traumatic coagulopathy and transfusion strategy
Thursday, November 6, 14
Protocols of Massive Transfusion
Thursday, November 6, 14
Case
• The patient who is resuscitated to MAP 65 mmhg
with 2 litres crystalloid.
Thursday, November 6, 14
Trias of death in trauma
Thursday, November 6, 14
Trias of death in trauma
Thursday, November 6, 14
Question & Discussion
Thursday, November 6, 14
Thursday, November 6, 14
Objectives
• DO2-VO2, oxygen debt concept
• Static Dynamic Parameters
• Principle of heart-lung interaction
monitoring
• Assessment of volume/fluid
responsiveness
• Macrocirculation - Microcirculation circle
concept
• Resuscitation end-points
Thursday, November 6, 14
Concept of oxygen debt
Thursday, November 6, 14
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
Carrying capacity
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
CaO2
Carrying capacity Haemoglobin SaO2
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
CaO2
Carrying capacity Haemoglobin SaO2
Delivery
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
CaO2
Carrying capacity Haemoglobin SaO2
Delivery
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
CaO2
Carrying capacity Haemoglobin SaO2
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
CaO2
Carrying capacity Haemoglobin SaO2
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
CaO2
Carrying capacity Haemoglobin SaO2 DO2
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
CaO2
Carrying capacity Haemoglobin SaO2 DO2
Organ distribution
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
CaO2
Carrying capacity Haemoglobin SaO2 DO2
Organ distribution
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
CaO2
Carrying capacity Haemoglobin SaO2 DO2
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
CaO2
Carrying capacity Haemoglobin SaO2 DO2
Diffusion
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
CaO2
Carrying capacity Haemoglobin SaO2 DO2
Diffusion
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
CaO2
Carrying capacity Haemoglobin SaO2 DO2
Diffusion
Distance
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
CaO2
Carrying capacity Haemoglobin SaO2 DO2
Diffusion
Distance
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
CaO2
Carrying capacity Haemoglobin SaO2 DO2
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
CaO2
Carrying capacity Haemoglobin SaO2 DO2
Cellular use
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
CaO2
Carrying capacity Haemoglobin SaO2 DO2
Cellular use
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
CaO2
Carrying capacity Haemoglobin SaO2 DO2
ATP = energy
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
CaO2
Carrying capacity Haemoglobin SaO2 DO2
ATP = energy
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
CaO2
Oxygen Supply (DO2) = DO2
Carrying capacity Haemoglobin SaO 2
SaO2 x Hb x CO
Delivery Cardiac Output Flow rate
ATP = energy
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
CaO2
Oxygen Supply (DO2) = DO2
Carrying capacity Haemoglobin SaO 2
SaO2 x Hb x CO
Delivery Cardiac Output Flow rate
ATP = energy
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
CaO2
Carrying capacity Haemoglobin SaO2 DO2
Heart Rate
X Stroke Volume Routinely measured
(HR) (SV)
Advance monitoring
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
CaO2
Carrying capacity Haemoglobin SaO2 DO2
Heart Rate
X Stroke Volume Routinely measured
(HR) (SV)
Advance monitoring
Thursday, November 6, 14
Uptake in the Lung Oxygenation PaO2
SaO2
Carrying capacity Hb
DO2=
Haemoglobin
CO.Hb.SaO2
Delivery Cardiac Output Stroke Volume.HR
ScvO2
Thursday, November 6, 14
Static Dynamic Parameters
Thursday, November 6, 14
1. OVERLOAD
2. INTRAOP
Traditional
Fluid Fluid Fluid Fluid + PRC? AWAKENING à
INCREASE VO2 OVER
practice DO2: Oxygen debt
BIS
45
90 BIS
45 1.5
BIS
55 BIS 1.0 MAC
80
MAP
Another
Bowel/
Vasc clamping/ Recovery Chapter
Prep bleeding
Anxiety
Sleep Peritonel
traction ICU
Duration
of
surgery George
2014
Thursday, November 6, 14
The
Concept
of
monitoring
haemodynamic
and
BIS
in
Perioperative
Goal-‐directed
Therapy
in
high
risk
surgery
Fluid
Oxygen
Delivery
Lactate <1,
SVV/PPV high Observe
ScvO2 >70%
CI low CI, MAP
SVV/PPV low
normal Lactate >1, Transfusion/
SVR low ScvO2 <70% PEEP
Anesthetic
agents
Macrodynamic Tissue
Oxygenation
60
Bi-‐spectral
Index
40
Stress
response
Premed
Recovery
Bowel/
Vascular
Anxiety clamping/
Peritonel
Intubation Incision traction Bleeding
Thursday, November 6, 14
• Preload
monitoring
:
Thursday, November 6, 14
• Preload
monitoring
:
Thursday, November 6, 14
• Preload
monitoring
:
Thursday, November 6, 14
• Preload
monitoring
:
Thursday, November 6, 14
• Preload
monitoring
:
Thursday, November 6, 14
Stroke
Volume
Variation
(SVV)
Thursday, November 6, 14
Stroke
Volume
Variation
(SVV)
Mechanical
Breath
Inspiratio Expiratio
Thursday, November 6, 14 n n
Stroke
Volume
Variation
(SVV)
Arterial Wave
Mechanical
Breath
Inspiratio Expiratio
Thursday, November 6, 14 n n
Stroke
Volume
Variation
(SVV)
Arterial Wave
Mechanical
Breath
Inspiratio Expiratio
Thursday, November 6, 14 n n
Stroke
Volume
Variation
(SVV)
Arterial
Wave
SVMin
Mechanical
Breath
Inspiratio Expiratio
Thursday, November 6, 14 n n
Large
SVV
Thursday, November 6, 14
Large
SVV
Thursday, November 6, 14
Large
SVV
Thursday, November 6, 14
Large
SVV
Thursday, November 6, 14
Large
SVV
Thursday, November 6, 14
Large
SVV
LVEDV (mL)
Preload
Thursday, November 6, 14
Normal
heart
Stroke
Volume
LVEDV (mL)
Preload
Thursday, November 6, 14
Normal
heart
SVV
13% Line
of
reference
Stroke
Volume
LVEDV (mL)
Preload
Thursday, November 6, 14
Normal
heart
Preload-‐independence:
If
CO
and
BP
drop
à
need
vasoactive
SVV
13% Line
of
reference
Stroke
Volume
LVEDV (mL)
Preload
Thursday, November 6, 14
Normal
heart
Preload-‐independence:
If
CO
and
BP
drop
à
need
vasoactive
SVV
13% Line
of
reference
Stroke
Volume
Preload-‐dependence:
If
CO
or
BP
drop
à
need
more
fluid
LVEDV (mL)
Preload
Thursday, November 6, 14
Normal
heart
SVV
10%
13% Line
of
reference
Stroke
Volume
LVEDV (mL)
Preload
Thursday, November 6, 14
Normal
heart
SVV
10%
13% Line
of
reference
Stroke
Volume
SVV
45
%
LVEDV
(mL)
Preload
Thursday, November 6, 14
Normal
heart
SVV
10%
13% Line
of
reference
SVV
Stroke
Volume
18 %
SVV
45
%
Preload-‐dependence
LVEDV
(mL)
Preload
Thursday, November 6, 14
Normal
heart
SVV
SVV 9
%
10%
13% Line
of
reference
SVV
Stroke
Volume
18 %
SVV
45
%
Preload-‐dependence
LVEDV
(mL)
Preload
Thursday, November 6, 14
Normal
heart
SVV
SVV 5
%
SVV 9
% Preload-‐independence
10%
13% Line
of
reference
SVV
Stroke
Volume
18 %
SVV
45
%
Preload-‐dependence
LVEDV
(mL)
Preload
Thursday, November 6, 14